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Abstract
Background: Despite a shared link to cognitive processing of health information
suggested by their definitions, information on the association between uncertainty and
health literacy is scarce. Their relationship has not been studied in pancreatic cancer
patients.
Aims: To evaluate uncertainty and health literacy in pancreatic cancer patients, examine
their bivariate correlation, and determine significant predictors.
Methods: This descriptive, cross-sectional study was conducted in a comprehensive
cancer center. Uncertainty was measured using the Mishel Uncertainty in Illness Scale Community and health literacy was measured using the Cancer Health Literacy Test 30.
Spearman’s rho tested correlation and linear regression models were used to test for
predictors. Bias corrected, accelerated bootstrap was used when regression residuals
violated normality.
Results: The sample (N=82) was predominantly male (55%), White/Caucasian (79%),
married 74%), and receiving neo-adjuvant treatment in anticipation of potential surgical
resection (49%). Mean age was 64.59 years ranging from 30 to 80. A significant but
weak correlation was noted between uncertainty and health literacy (rs = -.24, p = .032).
Health literacy was not a significant predictor of uncertainty after adjusting for age,
gender, education, race/ethnicity, and phase of care. Education was a significant
predictor of uncertainty (p = .001; ηp 2 = .217) and health literacy (p =.003; ηp 2 = .174).
Phase of care was a significant predictor of uncertainty (p = .001; ηp 2 = .221).
v

Conclusion: Health literacy and uncertainty had a significant albeit weak correlation.
Health literacy is multifaceted and some of its features were accounted for by other
socioeconomic and clinical variables. Education was a significant predictor of
uncertainty and health literacy. Significant differences in the ability to interpret health
events were found through the different phases of the pancreatic cancer experience.
Sample homogeneity restricted inferences and generalizability on effects of
race/ethnicity.
Keywords: uncertainty, health literacy, pancreatic cancer
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Summary of the Study
The research protocol “Uncertainty in Illness and Uncertainty in Pancreatic
Cancer Patients” was executed following approval from the Institutional Review Board
(IRB) of The University of Texas MD Anderson Cancer Center on May 10, 2017 and
from the Committee for the Protection of Human Subjects (CPHS) of The University of
Texas Health Science Center at Houston on June 5, 2017. The aims of this descriptive,
cross-sectional research study were to:
1. Describe uncertainty using the Mishel Uncertainty in Illness Scale – Community

instrument (MUIS-C) and health literacy using the Cancer Health Literacy Test –
30 (CHLT-30) in the pancreatic cancer population
2. Examine the association between uncertainty and health literacy in the pancreatic
cancer patient population
3. Examine if health literacy is a significant predictor of uncertainty after adjusting for
age, gender, race and ethnicity, education level, and disease treatment stage
Data collection began on June 9, 2017 and concluded on December 22, 2017.
Study instruments were administered to participants with pancreatic adenocarcinoma
recruited in the outpatient clinics at MD Anderson Cancer Center. Following application
of inclusion, exclusion, and sample selection criteria 91 participants were registered and
the final sample comprised of 82 evaluable pancreatic cancer patients.
Two study protocol amendments were submitted and approved by the Institutional
Review Board. The first approved amendment clarified that patients with pancreatic
adenocarcinoma who have either received oncologic treatment for another primary
malignancy or have active disease from another primary malignancy within the past 5
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years were ineligible for the study unless the other primary malignancy was a nonmelanoma skin cancer. The second approved amendment clarified that participants
complete the MUIS-C before their meeting with the physician. Study procedure already
adhered to this but it was specified with a formal amendment.
Descriptive statistics were employed to describe uncertainty and health literacy.
Spearman’s rho tested correlation and linear regression models tested for significant
predictors. Bias corrected, accelerated bootstrap was utilized when regression residuals
violated normality. The findings revealed a significant albeit weak correlation between
uncertainty and health literacy. Education level was a significant predictor of uncertainty
and health literacy. Significant differences in uncertainty levels were found through the
different phases of the pancreatic cancer experience. Sample homogeneity restricted
inferences and generalizability on effects of race/ethnicity.
A manuscript was written describing the background and significance of the
research questions along with methods, results, and implications for future research.
Appendices A-I contain supplemental information from the study including the IRB and
CPHS approval documents, MDACC protocol and IRB-approved amendments, study
consent form, study instruments, and human subjects research training certificates.
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Specific Aims
Uncertainty during the cancer illness experience is associated with poor health
outcomes (Lin et al., 2015). Although uncertainty has been studied in patients with
breast cancer, prostate cancer, brain tumors, renal malignancies, gynecologic
malignancies, and lymphoma (Bailey et al., 2011; Cahill et al., 2014; Elphee, 2008;
Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002; Mishel et al., 2009;
Parker et al., 2013), it has not been explored with a focus on pancreatic cancer patients.
Many of these studies show that uncertainty interventions aimed at enhancing knowledge
about diagnosis, management and surveillance as well as communication skills are
effective. However, assessment of uncertainty in the pancreatic cancer population is
necessary prior to effective implementation of interventions.
Pancreatic cancer has unique characteristics that warrant baseline studies prior to
implementing interventions found effective in other populations. The pancreatic cancer
experience is fraught with ambiguity, complexity, and unpredictability due to an
aggressive and recalcitrant biology, lack of prevention guidelines and screening standards
for the general population, and lack of expert conformity on the sequence of treatment for
patients with resectable disease (Halperin & Varadhachary, 2014; Reynolds & Folloder,
2014). These attributes of pancreatic cancer predispose patients to an illness experience
beset with uncertainty.
Uncertainty is defined as the inability to determine the meaning of illness-related
events and it is conceptualized as having associated antecedents and consequences
(Mishel, 1988). Antecedents and predisposing factors that can potentially influence
uncertainty are important to explore. One factor to examine is health literacy, defined as
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the capacity to obtain, process, and understand basic health information and services
needed to make appropriate health decisions (Dumenci et al., 2014). Health literacy has
emerged essential in health promotion studies and has been found influential in cancer
health outcomes (Altsitsiadis et al., 2012; Busch, Martin, DeWalt, & Sandler, 2015;
Halverson et al., 2015; Husson, Mols, Fransen, van de Poll-Franse, & Ezendam, 2015).
However, it has not been studied with a focus on pancreatic cancer patients. In fact, the
association between health literacy and uncertainty has yet to be explored in the cancer
population and there is a dearth of general information on the association between these
variables despite a shared connection to cognitive processing of health information
described in their respective definitions. Evaluating this association is valuable to
understanding the relevance and applicability of both in improving the care of pancreatic
cancer patients. The aims of the study are:
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel
Uncertainty in Illness Scale – Community instrument (MUIS-C)
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its
association to uncertainty in the pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower
levels of uncertainty in pancreatic cancer patients
Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic
cancer patients
3. Examine if age, gender, race/ethnicity, education status, and phase of care are
significant predictors of uncertainty and health literacy in the pancreatic cancer
population
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Hypothesis 3a: Education status, race/ethnicity, and phase of care are significant
predictors of uncertainty and of health literacy in pancreatic cancer patients
Hypothesis 3b: Age and gender are not significant predictors of uncertainty or of
health literacy in pancreatic cancer patients
Pancreatic cancer has distinct characteristics that predispose patients to
uncertainty. Successful understanding and navigation of the complexities of disease and
treatment that can mitigate uncertainty require proficient health literacy. Given the
cognitive processing of health information described in their respective definitions,
exploring the association between uncertainty and health literacy has merit and beneficial
implications for clinical practice and research. This study will explore uncertainty and
health literacy as distinct phenomena in the pancreatic cancer population and examine the
relationship between the two variables. This study will fill significant research gaps with
information that can improve clinical interventions, research and patient outcomes.
Background and Significance
Pancreatic cancer is the fourth leading cause of cancer deaths in the United States
(American Cancer Society [ACS], 2016). It has no established screening or prevention
guidelines, no hallmark symptoms to help distinguish disease at an early stage and 80%
of pancreatic cancer patients present with metastatic and locally advanced disease at
initial diagnosis (Chatterjee et al., 2012). This leaves a minority of patients eligible for
curative treatment. For patients undergoing treatment, there is debate among experts
regarding the sequence of therapy for patients with resectable disease (Brana Reynolds &
Folloder, 2014; Evans et al., 2008; Varadhachary et al., 2008). The National
Comprehensive Cancer Network (NCCI) recommends upfront surgery for potentially-
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resectable disease but expert consensus and a number of phase II clinical trials support
administration of neoadjuvant chemotherapy in selected patients with biopsy-proven
carcinoma prior to surgery (Halperin & Varadhachary, 2014). Even for patients who
complete treatment, the widely-acknowledged high recurrence rate undermines
confidence in having achieved long-term survival or cure. The 5-year survival rate for
pancreatic cancer remains low at 6% (ACS, 2016) and approximately 80% of patients
undergoing resection with curative intent develop distant metastasis or local recurrence
within five years of surgery (Halperin & Varadhachary, 2014). With a grim prognosis,
patients may become overly vigilant and mistakenly interpret symptoms unrelated to
malignancy as indications of disease recurrence. These factors contribute to uncertainty
throughout the patient’s illness experience from initial presentation to survivorship and
end-of life.
Uncertainty in Illness (Figure 1), is the inability to determine meaning of illnessrelated events (Mishel, 1988). It is a cognitive state that occurs when lack of adequate
knowledge leads to the inability to frame or categorize an event. Studies on uncertainty
in multiple cancer populations have utilized Mishel’s theoretical framework and have
suggested that uncertainty influences psychosocial adaptation and can affect disease
outcomes (Lin et al., 2015). Patients with cancer have also been found to benefit from
interventions aimed at addressing uncertainty during their illness (Mishel et al., 2009).
Studies on uncertainty have been conducted on patients with breast cancer (Germino et
al., 2013; Gil et al., 2006), prostate cancer (D. E. Bailey, Jr. et al., 2011; D. E. Bailey,
Mishel, Belyea, Stewart, & Mohler, 2004; Kazer, Psutka, Latini, & Bailey, 2013; Mishel
et al., 2002; Mishel et al., 2009; Wallace, 2005), gynecological malignancies (McCorkle

8

et al., 2009), renal malignancies (Parker et al., 2013), lymphoma (Elphee, 2008), and
brain cancer (Cahill, Gilbert, & Armstrong, 2014; Cahill, Lin, et al., 2014; Lin et al.,
2015). However, there is a research gap in examining uncertainty in the pancreatic cancer
experience and this gap requires research aimed at discovering baseline information so
that the uncertainty experienced by pancreatic cancer patients is evaluated before testing
and implementing interventions that have been found effective in other cancer
populations.
Although uncertainty has been explored in patients with other aggressive
malignancies, there are unique aspects to pancreatic cancer that warrant investigation
focused on this population. The lack of conformity of treatment sequence for curable
disease can cause confusion among newly diagnosed patients seeking information and
guidance in making treatment decisions. Conflicting information from clinicians on
whether one should pursue upfront surgery versus neo-adjuvant therapy can present
complex challenges that potentiate uncertainty and require a high level of health literacy
to parse through. There are other distinct aspects in the pancreatic cancer population such
as its widely-acknowledged high recurrence rate. A recent study that examined fear of
recurrence in 240 patients with pancreatic and peri-ampullary tumors included 94 patients
with pancreatic adenocarcinoma who had completed treatment with curative intent and
found that 37% of these patients reported frequent fearful thoughts, emotional
disturbance and functional impairment (Petzel et al., 2012). This concern over the
unpredictability of disease merits investigation. In a disease with vague but distressing
symptoms, aggressive and recalcitrant biology, and complex treatments, it is necessary to
assess precursors and associated factors to identify ways to mitigate uncertainty.
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Uncertainty is conceptualized by Mishel’s Uncertainty in Illness Theory (Figure1)
as having antecedents namely the stimuli frame, the patient’s cognitive capacity, and
structure providers that include patient education, social support, and credible authority
(Mishel, 1988). Stimuli frame is the composition and structure of the stimuli in illness
and treatment-related events and include event unfamiliarity, a lack of symptom pattern,
and lack of event congruence (Mishel & Braden, 1988). Structure providers are
information and support sources that help patients interpret variables in the stimuli frame.
Structure providers include credible authorities, education, and social support (Mishel,
1988). Cognitive capacity refers to the information-processing abilities that enable
patients to make sense of their experience (Mishel et al., 2009). The theory posits that an
inability to form a cognitive structure allowing for interpretation of illness-related events
can lead to uncertainty.

Figure 1. Uncertainty in Illness (Mishel, 1988)

One factor not explicitly addressed in the theoretical framework is health literacy,
defined by the Institute of Medicine and by the US Department of Health and Human
Services as the degree to which individuals have the capacity to obtain, process, and
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understand basic health information and services needed to make appropriate health
decisions (Cutilli & Bennett, 2009; Dumenci et al., 2014). Concept analyses have
ascribed reading and numeracy skills, comprehension, capacity to use information in
health care decision-making, and successful functioning as a health care consumer as
defining attributes of health literacy (Mancuso, 2008; Speros, 2005). Mancuso (2008)
classifies the attributes in three categories with the first being capacity which involves the
verbal, numerical, and social skills essential to advocating for oneself while negotiating
the health care system. The second is comprehension which involves the interaction of
logic, language, and experience essential to interpretation of information. The third is
communication which involves intake, processing, output, and feedback of messages
through speech, writing, or behavior. In addition to having these attributes, health
literacy has been described as having three classes (Nutbeam, 2000). Functional literacy
involves reading and writing skills for everyday situations while interactive literacy
involves advanced cognitive skills combined with social skills that allows a person to
extract information, derive meaning from different forms of communication and apply
such to changing circumstances (Nutbeam, 2000). Critical literacy involves cognitive
skills combined with social skills applied to critically analyze information and utilize
such to exert greater control over life events (Nutbeam, 2000; Chinn, 2011).
The definition and conceptualization of health literacy suggest a link to
uncertainty but thee variables have not been studied in association with each other in
cancer patients. In fact, there is a dearth of information on the relationship between these
variables in general. Literature search with the terms “uncertainty” and “health literacy”
using the Cumulative Index of Nursing and Allied Health Literature (CINAHL)
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generated only one report out of 12 results that actually studied the association between
the two variables and it was not in the cancer population. The report is an abstract by
Mock (2013) describing a pilot study to examine the correlation between health literacy
and uncertainty during acute hospitalization in 25 older adults with heart failure. The
abstract reported health literacy to be significantly correlated to uncertainty (Mock,
2013). A search using Pubmed generated no research reports examining the association
between these variables. One article discussed health literacy in advance care planning in
the context of proposing a theoretical model on Uncertainty in advance care planning for
African Americans (Melhadho and Bushy, 2011). The theory posits that improving
health literacy skills and addressing domains of the uncertainty in advance care planning
can promote end-of life discussions decision-making (Melhadho and Bushy, 2011). The
absence of prior research on the uncertainty of pancreatic cancer patients, the scarcity of
information on the relationship of uncertainty and health literacy, and the lack of
information on health literacy in the pancreatic cancer population underscores the
significance of this study.
Health literacy has evolved into an essential component in efforts to improve
health outcomes and is included in Healthy People 2020 as an objective in the promotion
of health communication (Office of Disease Prevention and Health Promotion; 2016).
According to the US Department of Education, only 12% of English-speaking adults
have proficient health literacy skills (Hepburn, 2012, US Department of Health and
Human Services, 2010). If this pattern holds true in the pancreatic cancer population, this
is a detriment to care access and delivery as patients in this population are often required
to navigate their way through information systems and interact with health care providers
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in order to understand their illness, access appropriate services and participate effectively
in health care decision making.
Health literacy has become more critical as patients try to navigate the everevolving health care environment and traverse information pathways. The promulgation
of web-based medical information, shifts in health policy and system access, as well as
advances in cancer management make health literacy essential to successful navigation of
the health care system. Exploring health literacy is especially significant in populations
such as pancreatic cancer patients where treatment decisions can be complex.
There is a growing body of evidence suggesting that limited health literacy negatively
affects cancer prevention and disease management behaviors. Studies in patients with
colon cancer (Pendlimari, Holubar, Hassinger, & Cima, 2012), breast cancer (Buki, Yee,
Weiterschan, & Lehardy, 2015; Halbach et al., 2015; Kamimura et al., 2016), cervical
cancer (Sentell, Braun, Davis, & Davis, 2015), prostate cancer (Kayser, Hansen-Nord,
Osborne, Tjonneland, & Hansen, 2015), lung cancer (Milne et al., 2015), and head and
neck cancer (Koay et al., 2013) have explored different aspects of health literacy and the
impact of poor literacy on health outcomes in these patient populations. Preparation
work for this proposal includes a search of Medline, Pubmed, CINAHL, and PsychINFO
to review the body of research on health literacy and cancer health outcomes. Fifteen
studies were found involving 11,326 patients with various cancers including melanoma,
colorectal cancer, prostate cancer, breast cancer, and lung cancer. The health outcomes
studied were quality of life (Husson, 2015; Song, 2012; Halverson, 2015; Milne, 2015),
distress (Koay, 2013), decision satisfaction and regret over decision outcomes (Hawley,
2008), mental well-being (Song, 2012), medication adherence (Rust, 2011; Rust, 2012),
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sunscreen and sunbed use (Altsitsiadis, 2012), receipt of treatment including
chemotherapy, reconstructive surgery, salvage hormone therapy, genetic counseling
(Mahal, 2015; Busch, 2015: Winton, 2016), disease status at diagnosis (Wolf, 2006), and
survivorship (Hulett, 2015). The results of the quantitative studies primarily support low
health literacy as having a negative association with health outcomes and the results of
the qualitative studies suggest that patients perceive low health literacy as a barrier to
good outcomes. The research gap in evaluating health literacy in the pancreatic cancer
population needs to be addressed. Because health literacy may be a critical and
modifiable factor in improving care and reducing health disparities, it is important to
explore this in pancreatic cancer patients as well.
This planned study will be conducted within the context of a conceptual
framework adapted from the Uncertainty in Illness Theory. The adaptation that will guide
this planned study is depicted in Figure 2 and focuses on antecedents of uncertainty with
incorporation of health literacy into the framework.

Figure 2. Antecedents to Uncertainty in Illness. Adapted from Uncertainty in Illness (Mishel,
1998)
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The study will also examine demographic factors as potential determinants of uncertainty
and health literacy to evaluate if there are demographic predictors that can guide future
research and identification of individuals who are more susceptible to uncertainty. Prior
health literacy assessment in 1,306 cancer patients found no significant mean difference
between men and women (p=.247) but the scores among African Americans were found
to be significantly lower (p < .0001) than White participants (Dumenci et al., 2014). This
study found that participants with limited health literacy consisted of an
overrepresentation of African-Americans, patients who were undereducated, and patients
with lower income (Dumenci et al., 2014). Meanwhile aggregate data on different
population subgroups described in the Uncertainty in Illness Scales Manual indicate no
difference in the mean scores based on gender or age but that scores decrease with an
increase in level of education (Mishel, 1997). These demographic variables will be
evaluated as this can influence the design and implementation of future studies and
intended population of intervention programs.
Innovation
Given the unique characteristics of pancreatic cancer, it is necessary to obtain baseline
information before translating findings from other populations to patients with pancreatic
cancer. This study will be innovative and significant to care delivery as it will explore
important variables that have not been studied in this population. With the growing
emphasis on health literacy, this study will explore health literacy as a structure provider
antecedent to uncertainty within the context of the Uncertainty in Illness model. The
innovation extends beyond theory testing and concept development as its practical
implications can significantly improve patient outcomes, nursing interventions, and guide
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future research efforts. The paucity of information on uncertainty and health literacy
specific to the pancreatic cancer population is a barrier to improving health literacy and
mitigating uncertainty. Results from this planned study can prove helpful in eventually
allowing nurses and health care givers to influence the patient’s ability to understand
illness events and process health information and services that enhance their engagement
in health decisions towards better outcomes.
Research Design and Methods
The study is designed as an observational, cross-sectional study seeking to
describe uncertainty in illness and health literacy in the pancreatic cancer population and
explore the relationship between variables. A cross-sectional design will be utilized to
gather information during a single period of data collection with no repeat
measures. Given the absence of prior studies on uncertainty and health literacy in
pancreatic cancer patients, this design is appropriate as an initial exploration that can
provide groundwork for future research.
Population, Sample, Sampling Procedure
The study population will be pancreatic cancer patients and the sample will be
recruited from the pancreatic cancer clinics in the Gastrointestinal Center at The
University of Texas MD Anderson Cancer Center. An estimated total of up to 91 patients
will be invited to participate. With an anticipated response rate of approximately 90%, an
analyzable sample size of 82 will be produced. The primary objective is to collect the
uncertainty and health literacy information in pancreatic cancer patients and assess the
correlation between uncertainty and health literacy. The primary endpoints are the
Mishel uncertainty scores which is defined as the summation of all the questions scores
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and the cancer health literacy test scores which is defined as the number of questions that
the patient answers correctly. With 82 patients in total, given the two-sided type I error
of 5%, we will have an 80% power to detect a Pearson’s correlation of 0.3 between
uncertainty score and cancer health literacy score. nQuery/nTerim version 3.0 was used
for the sample size justification.
The pancreatic surgical clinic had over 1900 visits from patients who had ICD-10
diagnosis codes corresponding to pancreatic cancer in the year 2015. This number
comprises a combination of patients who are newly diagnosed, under active treatment,
and survivors who attend clinic ongoing five days a week. It is expected that accrual will
be accomplished over a 6 month period. Consecutive sampling will be employed and
patients will be recruited in the order of their visit and appointment dates.
Inclusion Criteria
1. Patients with a diagnosis of biopsy-proven pancreatic adenocarcinoma who are
newly-diagnosed, receiving active treatment, receiving active oncologic
surveillance or treatment follow-up, or receiving survivorship care
a. Newly diagnosed – a patient who has biopsy confirmation of pancreatic
adenocarcinoma but has not started treatment
b. Active treatment – a patient who is currently receiving cancer therapy
(chemotherapy, surgery, radiation) or treatment for complication of
pancreatic adenocarcinoma
c. Oncologic surveillance – a patient who is receiving treatment-related
follow-up (post-op care, chemotherapy or radiation follow-up)
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d. Survivorship care – a patient who is 6 months or more from completion of
treatment and has no evidence of recurrence or active disease
2. Patients who meet the above criteria and are 18 years of age or older
Exclusion Criteria
1. Patients who have a history or current diagnosis of another primary malignancy
other than pancreatic adenocarcinoma
2. Patients unable to speak, read, or write in English will be excluded because the
instruments are in English
3. Pancreatic adenocarcinoma patients who are under 18 years of age
Recruitment
Patients who meet the eligibility criteria will be invited to participate in the study
when they present for a clinic visit. This will occur during a patient’s scheduled visit to
the clinic. Patients will not be required to report to clinic for the purpose of study
participation on days when they otherwise do not have a scheduled visit for cancer
treatment or follow-up. The voluntary nature of participation will be explained and
informed consent will be obtained from patients who agree to take part in the study. The
recruitment process will be as follows:
1. Primary investigator will review consecutive patients’ medical records to
determine eligibility
2. Primary investigator will approach the patient, explain the study and invite them
to participate
3. The primary investigator will explain the Informed Consent process and voluntary
nature of study participation
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4. The primary investigator will address patient questions
5. The principal investigator will obtain signatures for Informed Consent
6. A copy of the completed consents will be kept in the electronic health record
system
Patient Registration
Enrolled patients will be registered into the Clinical Oncology Research System
(CORe) which serves as the MD Anderson Cancer Center institutional patient data
management system.
Instruments
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be
used to measure uncertainty. The MUIS-C has 23 items scored 1 to 5 on a Likert
scale. The item scores are summed with a higher cumulative score indicating greater
uncertainty. The MUIS-C has been used extensively with cancer patients. The MUIS-C
was adapted from the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally
developed to evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al.,
2011). Items from the MUIS-A specifically relating to inpatient hospitalization were
removed and the remaining questions comprise the items for the MUIS-C version. The
MUIS-A was developed through expert analysis and validation of the MUIS-A was
utilized to support the validity of the MUIS-C (Bailey et al., 2011). In analyses of MUISC scores from 18 samples of chronically ill adults (total n=1068), Cronbach’s alpha
exceeded 0.85 in a large majority of the samples indicating the reliability of MUIS-C as
comparable to the 0.87 reported for the MUIS-A (Bailey et al., 2011).
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The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be
used to measure health literacy. The 30-item CHLT-30 was created to assess literacy
along the cancer health literacy continuum. Its development was described in a
publication of a study involving 1,306 adults with heterogenous cancer diagnoses,
educational attainment, and health insurance and marital status. Pancreatic cancer was
not listed as a category among the 11 diagnostic cancer types represented by the
participants in the study sample. The reliability evidence for the CHLT-30 was a
Cronbach’s alpha of 0.88, McDonald’s omega of 0.89, 2-week test–retest reliability of
0.90, and 6-month test–retest reliability of 0.90. There was support for the
unidimensional scale and all variables had significant factor loadings of >
0.44. Structural equation modeling supported external validity with self-confidence in
engaging in health decisions specified as a latent variable measured by two positively and
two negatively worded items. The test score is the total number of correct responses and
ranges from 0 to 30. The instrument response time ranges from 10-15 minutes (Dumenci,
et. al., 2014).
A Patient Demographic Form will be utilized to record demographic information
including age, gender, education status, ethnicity, and marital status. The time to
complete all instruments should not exceed 20 minutes.
Data Collection Procedures
Enrolled patients will complete the instruments in the clinic. Collaboration and
coordination with the clinic team seeing the patients will be established for the study prior
to beginning screening, recruitment, and enrollment.
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1. Data will be collected by paper and pencil surveys with the research staff entering
information into the web-based REDCap application hosted by MD Anderson
Cancer Center (https://redcap.mdanderson.org)
2. A member of the research staff will be available during the time the patient is
completing the instruments
3. The research staff may not provide any answers to the specific questions on the
questionnaire but can address questions about study participation or the process of
form completion
4. Only the patient may complete the form. Family members or patient companions
to the visit may not answer or complete the forms. If there are deficits that makes
reading the questionnaire or writing the responses difficult, the questionnaire can
be read to the patient by the research staff or the patient companion and the
responses recorded according to the patient response
5. Research staff will review the forms to ensure completeness and will transport the
completed forms to a secure location in the primary investigator’s office
The time to complete the instruments should not exceed 20 minutes. The primary
investigator or designated research staff will enter the data into a secure database. Data
entry and instrument scoring will be conducted according to the instrument manuals and
study protocol prepared for the study.
Data Analysis
Questionnaire scores will be calculated based on standardized manuals
associated with each survey instrument. Descriptive statistics will be used to
summarize scores of the questionnaires according to respective scoring manuals for
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each of the measures. The distribution of each continuous variable will be summarized
by its mean, standard deviation, median, and range. The distribution of each
categorical variable will be summarized in terms of its frequencies and percentages.
The difference in uncertainty and health literacy scores will be assessed between
groups (e.g. gender, education levels) by a two-sample t-test or ANOVA if the data is
normally distributed; otherwise a Wilcoxon rank sum or Kruskal-Wallis test will be
used. The association between uncertainty scores and health literacy score will be
examined by Pearson correlation. To identify factors associated with uncertainty or
health literacy scores of the survey measures, for example, the patient education status,
age, ethnicity, and gender, multivariate linear regression will be performed to examine
their effects.
Specifically, the hypotheses testing and anticipated results are as follows:
1.

Describe uncertainty in the pancreatic cancer patient population using the MUIS this primary, exploratory aim will assessed using descriptive analysis

2.

Describe health literacy using the CHLT-30 and its association to uncertainty in the
pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with
lower levels of uncertainty in pancreatic cancer patients - Pearson product
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho
will be used if there is not a linear relationship or normal distribution. The
anticipated result will be an inverse linear association between uncertainty and
health literacy.
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Hypothesis 2b: Health literacy is an independent significant predictor of
uncertainty in pancreatic cancer patients - Health literacy will be included in
multivariate regression to evaluate if it is a significant predictor of uncertainty.
3.

Examine significant demographic predictors of uncertainty and health literacy in the
pancreatic cancer population
Hypothesis 3a: Education status and ethnicity are significant predictors of
uncertainty and of health literacy in pancreatic cancer patients – Multiple linear
regression will be performed to determine if education status and ethnicity are
significant predictors for uncertainty and multivariate regression will be also be
performed assess if they are significant predictors for health literacy as well. The
anticipated results will be that education status and ethnicity will be significant
predictors for both health literacy and uncertainty.
Hypothesis 3b: Age and gender are not significant predictors of uncertainty or of
health literacy in pancreatic cancer patients - Multivariate regression will be
performed to determine if education status and ethnicity are significant predictors for
uncertainty and multivariate regression will be also be performed assess if they are
significant predictors for health literacy as well. The anticipated results will be that
neither age not gender will come out as significant predictors for either uncertainty
or health literacy.

Study Limitations
The lack of prior studies on uncertainty and health literacy focused on the
pancreatic cancer population is a constraint as there is limited information to guide this
investigation in this population. Sampling bias will be a concern as this sample will be
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recruited from patients who have the ability to navigate the referral system and travel
then to access care at a high-volume comprehensive cancer center. The participants will
thus potentially represent patients who have higher income and better ability to traverse
the health care system. As such, one would have to emphasize that the study results will
have generalizability limitations to the general population of pancreatic cancer patients.
Nonetheless, the information from this initial study on uncertainty and health literacy will
provide valuable guidance for future studies. Patients who perceive their health literacy
to be low may also be more apt to decline participation over concern of a stigma related
to low health literacy.
Utilizing a cross-sectional design is deemed appropriate for this initial study on these
concepts but it does not allow for repeated measures to assess for change in uncertainty
levels as patients go through the phases of cancer treatment. A future study can be done
as a longitudinal repeated measures design to examine a patient’s the fluctuation or
differences in uncertainty scores between the different phases of care after baseline
information from this study has been obtained.
Strategies to Overcome Potential Problems
One concern to overcome is that patients may find it daunting to complete
questionnaires during a time when they are stressed with emotional or physical
challenges related to their illness. The investigator will take the time to explain the
enrollment and study process to the patient, acknowledge the patient’s valuable
contribution, and elucidate the advances that can result from participation in the study. It
is also important to prevent the perception that there is judgment of skills and capabilities
so emphasis will be placed on the overarching goal of assessing the needs of pancreatic
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cancer patients to help providers enhance their communication skills and improve the
way they engage patients in health care decisions. The primary investigator will stress the
importance for health providers to understand areas for improvement in their patient
interactions in order to promote improved partnerships with their patients.
Human Subject Protection
Permission to conduct the study will be requested from the Institutional Review
Board (IRB) of The University of Texas MD Anderson Cancer Center where the study
will be conducted. Reciprocal permission will be requested from the Committee for the
Protection of Human Subject of University of Texas-Houston following the guidelines of
the university in partnership with MD Anderson Cancer Center.
Participants will be provided information on the potential risks, benefits, and the
importance of knowledge gained from the study. The voluntary nature of the study will
be emphasized and it will be explained to patients and clinicians that declination of
participation in the study will not affect clinical treatment and/or care. The clinical team,
case management or social work team assigned to the patient will be notified if the
patient expresses questions or concerns about increased uncertainty about their care or
raise questions about understanding of or access to resources.
The exclusion of patients who are non-English speaking is due to the lack of an
instrument version translated for the assessment of health literacy in non-English
speaking patients. As such, it would be unsuitable and detrimental to the validity of the
study not to exclude them.
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Confidentiality
To ensure confidentiality, paper forms of the completed instruments will be
secured in a locked cabinet. All electronic files of questionnaires and the interviews will
be kept on a password-protected secure server. Research staff who require access to
electronic or paper files for analysis must relinquish access when analysis is not
occurring. Files may only be accessed may not be kept by study personnel when not in
use. Digital files are identified with participant study numbers only and not with names,
medical record numbers, or other identifying information. When all analysis has been
completed and all study results have been reported, the electronic and paper files will be
stored securely in perpetuity.
Timeline
The study is expected to take 12 months from the time the proposal submission. The
specific time points for each step of the study including dissertation writing and defense
is outlined in Table 1 below.
Table 1
Study Timeline

STUDY TIMELINE
2016
ACTIVITY
Proposal
Preparation
Proposal
Defense

FALL

2017
SPRING

SUMMER

FALL
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IRB, CPHS
Approval
Prepare
instruments
Prepare
Survey Sites
Train Study
Staff
Recruitment/
Data
Collection
Database
Input

Statistical
Analysis
Writing and
Revisions
Dissertation
Defense
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Uncertainty in Illness and Health Literacy in Pancreatic Cancer Patients
Introduction
Uncertainty in illness is the inability to determine meaning of illness-related
events (Mishel, 1988). It is a cognitive state that occurs when lack of cues leads to an
inability to predict outcomes or meaningfully interpret experiences. Health literacy is the
degree to which individuals have the capacity to obtain, process, and understand basic
health information and services needed to make appropriate health decisions (Cutilli &
Bennett, 2009; Dumenci et al., 2014). Despite a shared link to cognitive processing of
health information suggested by their definitions, information on the association between
uncertainty and health literacy is scarce. Neither uncertainty nor health literacy has been
studied with a focus on pancreatic cancer patients whose illness experience is fraught
with complex events that predispose to uncertainty and require proficient health literacy
to manage effectively. This study was conducted to obtain information constructive to
future research and patient care outcomes.
Background
Studies on uncertainty in multiple cancer populations have utilized Mishel’s
theoretical framework and suggest that uncertainty influences psychosocial adaptation
and has been associated with diminished quality of life, emotional distress, perceived
stress, lack of resourcefulness, and less emotional well-being (Kurita, Garon, Stanton, &
Meyerowitz, 2013; Lin et al., 2015; Hagen et al., 2015; Zhang, 2017). Patients with cancer
have been found to benefit from interventions addressing uncertainty (Mishel et al., 2009;
Gil et al., 2006). Studies exploring uncertainty have been conducted on patients with
breast cancer (Germino et al., 2013; Gil et al., 2006), prostate cancer (D. E. Bailey, Jr. et
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al., 2011; D. E. Bailey, Mishel, Belyea, Stewart, & Mohler, 2004; Kazer, Psutka, Latini,
& Bailey, 2013; Mishel et al., 2002; Mishel et al., 2009; Wallace, 2005), gynecological
malignancies (McCorkle et al., 2009), renal malignancies (Parker et al., 2013), lymphoma
(Elphee, 2008), and brain cancer (Cahill, Gilbert, & Armstrong, 2014; Cahill, Lin, et al.,
2014; Lin et al., 2015). However, there are no published studies focusing on uncertainty
in pancreatic cancer patients despite various factors in the pancreatic cancer experience
that predispose to increased levels of uncertainty including the recalcitrant biology, grim
prognosis, and lack of consistency in treatment sequence recommendations. Discovery
of baseline information is required before testing and implementing uncertainty
interventions found effective in other cancer populations.
Although uncertainty has been explored in patients with other aggressive
malignancies, there are unique aspects to pancreatic cancer that warrant disease-specific
investigation. Pancreatic cancer is the fourth leading cause of cancer deaths in the United
States with 55,440 new cases and 44,330 deaths in estimated in 2018 (American Cancer
Society [ACS], 2018). It has no established screening or prevention guidelines, no
hallmark symptoms to promote early diagnosis and 80% of patients present with
metastatic or locally-advanced disease at initial diagnosis (Chatterjee et al., 2012).
Moreover, the widely-acknowledged high recurrence rate undermines confidence in
achieving long-term survival. The low 5-year relative survival rate for pancreatic cancer
of 8% (American Cancer Society, 2018) carries a forbidding outlook that can cause
patients to become overly vigilant and mistakenly interpret symptoms unrelated to
malignancy as indicators of recurrence.
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For patients with localized disease, the 5-year survival rate is only 32%
(American Cancer Society, 2018). In these patients who are eligible for curative
resection, there is debate among experts regarding the sequence of therapy (Reynolds &
Folloder, 2014; Evans et al., 2008; Varadhachary et al., 2008). While the National
Comprehensive Cancer Network (NCCN) recommends upfront surgery for potentiallyresectable disease (National Comprehensive Cancer Network, 2017), expert consensus
and a number of phase II clinical trials support administration of neoadjuvant
chemotherapy in selected patients with potentially-resectable, biopsy-proven
adenocarcinoma prior to surgery (Halperin & Varadhachary, 2014; Evans et al., 2008;
Varadhachary et al., 2008). The lack of conformity in treatment sequence
recommendations can lead to confusion among patients seeking information and
guidance in making treatment decisions. Conflicting information from clinicians on
whether one should pursue upfront surgery versus neo-adjuvant therapy can present
complex challenges that potentiate uncertainty and require a high level of health literacy
to process.
Various factors contribute to uncertainty throughout the phases of care from the
ambiguity at initial presentation, the complexity of treatment planning, the
unpredictability of recurrence during survivorship, and the unfamiliarity with how things
evolve at end-of life. A study that examined fear of recurrence in 240 patients with
pancreatic and peri-ampullary tumors included 94 patients with pancreatic
adenocarcinoma who completed treatment with curative intent and found that 37% of
these patients reported frequent fearful thoughts, emotional disturbance, and functional
impairment (Petzel et al., 2012). In a disease with vague distressing symptoms,
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aggressive course, and complex treatments algorithms, it is necessary to assess precursors
and identify ways to mitigate uncertainty.
As depicted in Figure 1, uncertainty is conceptualized as having antecedents
namely the stimuli frame, the patient’s cognitive capacity, and structure providers that
include patient education, social support, and credible authority (Mishel, 1988). Stimuli
frame comprises of event unfamiliarity, a lack of symptom pattern, and lack of event
congruence experienced by patients during illness (Mishel & Braden, 1988). Structure
providers are resources that help patients interpret variables in the stimuli frame.
Structure providers include credible authorities, education, and social support (Mishel,
1988). Cognitive capacity refers to the patient’s information-processing abilities that
enable patients to make sense of their experience (Mishel et al., 2009). The theory
suggests that an inability to form a cognitive structure allowing for interpretation of
illness-related events can lead to uncertainty.
One factor not explicitly addressed in the framework is health literacy, defined by
the Institute of Medicine and by the US Department of Health and Human Services as the
degree to which individuals have the capacity to obtain, process, and understand basic
health information and services needed to make appropriate health decisions (Cutilli &
Bennett, 2009; Dumenci et al., 2014). Concept analyses have ascribed reading and
numeracy skills, comprehension, capacity to use information in health care decisionmaking, and successful functioning as a health care consumer as defining attributes of
health literacy (Mancuso, 2008; Speros, 2005). Mancuso (2008) classifies the attributes
in three categories with the first being capacity which involves the verbal, numerical, and
social skills essential to advocating for oneself while negotiating the health care system.
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The second is comprehension which involves the interaction of logic, language, and
experience essential to interpretation of information. The third is communication which
involves intake, processing, output, and feedback of messages through speech, writing, or
behavior. In addition to having these attributes, health literacy has been described as
having three classes (Nutbeam, 2000). Functional literacy involves reading and writing
skills for everyday situations while interactive literacy involves advanced cognitive skills
combined with social skills that allows a person to extract information, derive meaning
from different forms of communication and apply such to changing circumstances
(Nutbeam, 2000). Critical literacy involves cognitive skills combined with social skills
applied to critically analyze information and utilize such to exert greater control over life
events (Nutbeam, 2000; Chinn, 2011).
The definition and conceptualization of health literacy suggest a link to
uncertainty but their association has not been studied in cancer patients. A review of
literature review did not yield any published research reports in this area. The search
only revealed a conference abstract describing a pilot study in 25 hospitalized older
adults with heart failure which showed a significant correlation (r = -.415; p = .039)
between health literacy and uncertainty (Mock & Sethares, 2013). Another article
discussed health literacy in advanced care planning in the context of proposing a
theoretical model that posits improving health literacy skills and addressing domains of
uncertainty can promote end-of-life discussions and decision making (Melhadho &
Bushy, 2011). The dearth of information on the relationship of these variables and the
lack of information on uncertainty and health literacy in the pancreatic cancer population
underscore the significance of this study.
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Health literacy has evolved into an essential component in efforts to improve
health outcomes and is included in Healthy People 2020 as an objective in the promotion
of health communication (Office of Disease Prevention and Health Promotion; 2016).
The promulgation of web-based medical information, shifts in health policy and system
access, as well as advances in cancer care involve proficient health literacy to process
appropriately. According to the US Department of Education, only 12% of Englishspeaking adults have proficient health literacy skills (Hepburn, 2012, US Department of
Health and Human Services, 2010). If this holds true in the pancreatic cancer population,
this is detrimental to care access and delivery as patients in this population are often
required to navigate through complex information systems and interactions with
clinicians in order to understand their illness, access appropriate services, and participate
effectively in decision making.
There is a growing body of evidence suggesting that limited health literacy also
negatively affects cancer prevention and disease management behaviors. A study on
1306 cancer patients found that when controlling for potentially confounding variables,
an inverse relationship was found between health literacy and number of inpatient
hospitalizations (β = -0.041, p =.009) as well as health literacy and total number of
hospital days ( β = -0.028. p = .023) (Cartwright et al, 2017). Studies in patients with
colon cancer (Pendlimari, Holubar, Hassinger, & Cima, 2012), breast cancer (Buki, Yee,
Weiterschan, & Lehardy, 2015; Halbach et al., 2015; Kamimura et al., 2016), cervical
cancer (Sentell, Braun, Davis, & Davis, 2015), prostate cancer (Kayser, Hansen-Nord,
Osborne, Tjonneland, & Hansen, 2015), lung cancer (Milne et al., 2015), and head and
neck cancer (Koay et al., 2013) have also explored different aspects of health literacy and
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the impact of poor literacy on outcomes. Review of Medline, Pubmed, CINAHL, and
PsychINFO on health literacy and cancer outcomes revealed outcome studies on patients
with various cancers including melanoma, colorectal cancer, prostate cancer, breast
cancer, and lung cancer. The health outcomes investigated were quality of life (Husson,
2015; Song, 2012; Halverson, 2015; Milne, 2015), distress (Koay, 2013), decision
satisfaction and regret over decision outcomes (Hawley, 2008), mental well-being (Song,
2012), medication adherence (Rust, 2011; Rust, 2012), sunscreen and sunbed use
(Altsitsiadis, 2012), receipt of treatment including chemotherapy, reconstructive surgery,
salvage hormone therapy, genetic counseling (Mahal, 2015; Busch, 2015: Winton, 2016),
disease status at diagnosis (Wolf, 2006), and survivorship (Hulett, 2015). The results of
the quantitative studies primarily support low health literacy as having a negative
association with health outcomes and the results of the qualitative studies suggest that
patients perceive low health literacy as a barrier to good outcomes.
The paucity of information on uncertainty and health literacy specific to the
pancreatic cancer population is a hindrance to improving literacy and mitigating
uncertainty. Because these factors may be modifiable and essential to improving care, it
was important to address the information and research gap. The adapted model used for
this study posits that health literacy could be a structure provider in the uncertainty
framework (Figure 2).
Objectives
The purpose of the study was to evaluate uncertainty and health literacy in the
pancreatic cancer patient population, determine an association between them, and
evaluate predictors. The aims and hypotheses were:
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1. Describe uncertainty using the Mishel Uncertainty in Illness Scale – Community

instrument (MUIS-C) and health literacy using the Cancer Health Literacy Test – 30
(CHLT-30) in the pancreatic cancer population
2. Examine the association between uncertainty and health literacy in the pancreatic
cancer patient population
Hypothesis: Higher levels of health literacy are significantly correlated with lower
levels of uncertainty in pancreatic cancer patients
3. Examine if health literacy is a significant predictor of uncertainty after adjusting for age,
gender, race and ethnicity, education level, and disease treatment stage
Hypothesis 3a: Health literacy is a significant predictor of uncertainty after adjusting for
age, gender, education level, race and ethnicity, and disease treatment stage
Hypothesis 3b: Education level, race, and disease treatment stage are significant
predictors of uncertainty and of health literacy in pancreatic cancer patients
Methods
Design
The study was conducted using observational, cross-sectional design. It was
approved by the MD Anderson Cancer Center (MDACC) Institutional Review Board as
well as by Committee for the Protection of Human Subjects of The University of Texas
Health Science Center in Houston.
Variables and Measurements
Uncertainty was operationalized as the score on the MUIS-C (Appendix A), and
health literacy operationalized as the score on the CHLT-30 (Appendix B). The MUIS-C
has 23 items scored from 1 to 5 on a Likert scale. The item scores are summed with a
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higher cumulative score indicating greater uncertainty. For the purpose of this study,
cumulative scores on the MUIS-C were treated as continuous variables in accordance
with developer intent. The MUIS-C has been used extensively with cancer patients. It
was adapted from the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally
developed to evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al.,
2011). Items from the MUIS-A specifically relating to inpatient hospitalization were
removed and the remaining questions comprise MUIS-C items. The MUIS-A was
assessed for content analysis and its validation information was utilized to validate the
MUIS-C (Bailey et al., 2011). In analyses of MUIS-C scores from 18 samples of
chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a large majority
of the samples indicating the reliability of MUIS-C as comparable to the 0.87 reported for
the MUIS-A (Bailey et al., 2011).
The 30-item CHLT-30 was created to assess literacy along the cancer health
literacy continuum (Dumenci, et. al., 2014). It has been tested in 1,306 adults with
heterogenous cancer diagnoses, educational attainment, as well as health insurance and
marital status although pancreatic cancer was not specified as a category in the most
common cancer types ascribed to these study participants (Dumenci at al., 2014).
Reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of
0.90. There was support for the unidimensional scale and all variables had significant
factor loadings of > 0.44. Structural equation modeling supported external validity with
self-confidence in engaging in health decisions specified as a latent variable measured by
two positively and two negatively worded items. The developers indicated that it takes
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10-15 minutes to complete the CHLT-30 electronically with a tablet device that also read
the questions to patients. CHLT-30 score is the total number of correct responses and
ranges from 0 to 30 (Dumenci, et. al., 2014).
The demographic information was obtained using a demographic form (Appendix
C). Education was assessed by the highest level attained with the choices being “some
high school”, “completed high school”, “vocational school”, “some college”, “completed
college” “some graduate school” and “completed graduate school”. Disease treatment
phases included “before surgery”, “within 2 years after surgery”, “within 5 years after
surgery”, “5 years after surgery” and patients whose care did not include plans for
resection were noted as “no surgery planned”. The 2-year mark following surgery was
selected to account for the high recurrence rate most frequently seen within 2 years
following surgical resection (Heye, 2011). The 5-year mark was selected as this
represents a widely-acknowledged and reported survival threshold.
In addition to the demographic and clinical information, the form also prompts
inquiry into electronic devices used by the patient, if they use a mobile phone for
purposes other than phone calls, and if they use the electronic health record to access
their personal medical information.
Participants
Sample size justification was calculated using nQuery/nTerim version 3.0
assigning a two-sided type I error of 5% with 80% power to detect a correlation of 0.3
between uncertainty score and cancer health literacy score. It was determined that a
sample of 82 participants was needed. A total 91 were invited with allowance for 10%
attrition. The recruitment and accrual primarily occurred in surgical clinics. Patients
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presenting to MDACC Gastrointestinal Clinic were screened for eligibility by the
primary investigator who recruited eligible patients on a consecutive basis.
Eligibility Criteria
Eligibility criteria included patients with a diagnosis of pancreatic
adenocarcinoma who are 18 years or older and receiving care in an MDACC outpatient
clinic. Excluded were patients with pancreatic adenocarcinoma unable to speak, read,
and write English. Patients with pancreatic adenocarcinoma who have evidence of active
disease or have received oncologic treatment for another primary malignancy, except
non-melanoma skin cancer, within the past 5 years were excluded.
Data Collection and Management
Recruitment and data collection schedules were coordinated with the clinical
team. Patients were recruited, consented, and administered the questionnaires during
clinic visits before being seen by the physician. The voluntary nature of participation, the
study purpose, requirements and eligibility criteria were discussed. Informed consent
was obtained via the electronic program used by MDACC for obtaining and storing
consents in the electronic health record. The patient demographic form was completed
with the patient and thereafter, the MUIS-C and CHLT-30 were administered through
pen and paper approach according to protocol which called for the MUIS-C to be
completed prior to the patients’ visits with the physician. Participants were enrolled and
issued a participant number using the Clinical Oncology Research System (CORe)
program which serves as the MDACC institutional research management system. The
primary investigator was present in clinic to collect the instruments at the conclusion of
the patient’s participation.
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The MUIS-C and CHLT-30 were manually scored by the primary investigator
according to the instrument manuals. After manual scoring, the responses were entered
into a secure database developed using REDCap hosted by MDACC for data
management. Questions and response options for the MUIS-C and CHLT-30 were
programmed into REDCap with encoded formula that automatically generate scores
based on entered participant responses. Every participant’s REDCap score was
compared with their manually-derived score and the REDCap entry was saved after a
match between manually-derived and computer-generated scores was confirmed. The
MUIS-C items that required reverse scoring were noted and programmed accordingly.
Instrument hard copies were stored in secure files in the primary investigator’s office.
Data Analysis
The REDCap database was exported to the IBM SPSS Statistics for Windows
version 24 (IBM Corp). Significance for all tests were set at p < .05.
Descriptive analysis was used to describe uncertainty and health literacy as
stated in Aim 1. Frequencies, percentages, central tendencies and variability measures
were determined. Because CHLT-30 scores were found to be non-normally
distributed, differences in group scores for both MUIS-C and CHLT-30 were analyzed
using the non-parametric Kruskal Wallis test for the sake of consistency. Pair-wise
testing with Bonferroni adjustment was used to ascertain where significant differences
existed between levels of significant predictor groups.
To address Aim 2 Spearman Rho testing was used to evaluate the correlation
between MUIS-C and CHLT-30 scores. This non-parametric test was selected due to the
non-normality of the CLHT-30 scores distribution.
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Aim 3a was addressed with multiple regression using the general linear model
to determine if CHLT-30 score is an independent predictor of MUIS-C score
accounting for age, gender, education, race and phase of care. Because a clear linear
relationship between uncertainty and health literacy was not present, CHLT-30 scores
were transformed into categorical predictors based on quantiles. Aim 3b tested the
hypothesis that race/ethnicity, education level, disease treatment phase are significant
predictors of MUIS-C and CHLT-30 scores. General linear model was used to test
this hypothesis. The CHLT-30 score distribution violated the assumption of normality
so an added measure utilizing bias corrected and accelerated bootstrap with 5,000
sampling iterations was incorporated into the analysis.
Results
Demographics and clinical characteristics
Ninety-one participants were enrolled and all had complete demographic data for
age, marital status, racial/ethnic self-identification, gender, disease treatment phase, use
of electronic devices and access utilization of their electronic health records. Of these, 82
completed both the MUIS-C and CHLT-30 and this group is used for analysis. The
difference in the total and the evaluable samples was due in part to some participants not
completing the instruments before being seen by the physician. There were also
participants who decided not to complete instruments after starting for reasons that
included not wanting to answer mathematic questions, being tired, instrument completion
time being lengthy, or the health literacy questions being more difficult than anticipated.
As summarized in Table 1, the study sample (N=82) comprised of 45 males
(55%) and 37 (45%) females with an average age of 64.59 years ranging from 30 to 80
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years and were predominantly married (n = 61, 74%). Racial/ethnic self-identification
was primarily White/Caucasian (n = 65, 79%) with Black/African American (n = 7, 8%),
Asian (n = 4, 5%), and Latino/Hispanic (n = 7, 8%) comprising the remainder of the
sample. The participants’ education levels ranged from high school to completion of a
graduate degree.
The sample primarily consisted of patients in surgical oncology clinics and the
majority were receiving care in anticipation of eventual surgical resection (n = 40; 48%).
The disease treatment phase composition also included patients within 2 years after
surgery (n = 30, 37%), within 5 years after surgery (n = 5, 6%), 5 or more years after
surgery (n = 2, 2%), and some with no surgery planned (n = 5, 6%). With respect to use
of electronic devices, participants predominantly answered yes to owning a cellular phone
(n = 81, 99%), reported using their phone for purposes other than phone calls (n = 78,
95%), and reported utilization of the electronic health record access to look up their
medical information (n = 76, 93%).
This sample composition resembles that of the MDACC Surgical Oncology
pancreatic adenocarcinoma database of patients who received care from 2000 - 2017. Of
8,875 patients, 56% in the database were male. Among the 8,763 patients who disclosed
racial/ethnic self-identification, 77% were White/Caucasian and 76% of those who
reported marital status were married.
Table 2 includes the sample means and medians along with variability measures.
MUIS-C mean for this sample was 46.46 (SD = 12.94) with a median of 46.5 (IQR = 21).
CHLT-30 mean was 26.65 (SD = 3.30) with a median of 28 (IQR = 4).
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Group Differences
Kruskal Wallis testing revealed MUIS-C scores to be significantly different for
levels of education (H = 15.44, p = .009), phase of care (H = 10.70, p = .030), and
race/ethnic self-identification (H = 8.39 p = .039) as summarized in Table 3. The
differences are detailed in Table 5 showing that the significance in education level (H =
44.16, p = .026) is between those whose highest educational attainment was high school
(Mdn = 56.5, IQR = 17) and those who had some graduate schooling (Mdn = 35, IQR =
10). Post-hoc testing did not specify where the differences lie within phase of care.
Significant difference in uncertainty scores within race/ethnic self-identification (H =
38.06, p = .024) was between Latino/Hispanics (Mdn = 36, IQR = 16) and Black/African
Americans (Mdn = 54, IQR = 11).
CHLT-30 scores are summarized in Table 4 showing a significant difference for
race/ethnic self-identification (H = 9.19, p = .0.27) but post-hoc pairwise testing did not
show the source of the differences. There was a significant difference in CHLT-30
scores between education levels (H=18.33, p = .003) and post-hoc pairwise testing
revealed significance (H= -29.75, p = .010) in the scores of those who completed high
school as highest attainment (Mdn = 24.5; IQR 4) and those who completed college (Mdn
= 28, IQR = 3). High school graduates also had significant difference in CHLT-30 scores
(H= -25.82, p = .048) compared with those who attended some college (Mdn = 28, IQR =
4). Additionally, there was a significant difference (H = -49.20, p = .006) between high
school graduates and those who attended some graduate school (Mdn = 29; IQR = 2) and
a significant difference (H= -34.40, p = .010) in the scores between those who completed
high school and those who completed a graduate degree (Mdn = 28.5, IQR = 2).
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For the remainder of the analysis and reporting, education and disease treatment
phase levels were re-classified to improve the balance of the group sizes. The vocational
school participants (n = 3) were combined with those who attended some college (n = 26)
as these levels are proximal to each other in the order of educational attainment and there
was no significant difference in either the MUIS-C or CHLT-30 scores between the
levels. They had the same CHLT-30 median of 28 and the MUIS-C score means for
those who attended vocational school were closer to the score means of those who had
some college than to those who completed high school (Table 3). The order of
educational attainment as well as the score medians and means also factored into the
decision to combine those who attended some graduate school (n = 4) with those who
completed graduate degrees (n = 12).
Furthermore, due to only having two participants past the 5-year threshold in the
disease phase category, they were combined with patients who were within 5-years after
surgery. Of note, Kruskal Wallis analysis with post-hoc testing found no significant
differences in the MUIS-C or CHLT-30 scores between participants within these two
group levels. The phase of this new group was labeled “2 or more years after surgery”.
Correlation
Spearman Rho testing yielded a significant yet weak correlation between MUIS-C
and CHLT-30 scores with a coefficient of rs(81) = -.24 ( p = .032). Education as an
ordinal variable was also evaluated for its association with MUIS-C and CHLT-30 and
had a statistically significant albeit weak correlation with uncertainty (rs (81) = .23, p =
.038) with health literacy (rs (81) = .38, p < .001).
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Predictors of Uncertainty
General linear model was utilized to assess significant predictors of uncertainty.
Because of the non-linear relationship (Figure 3) between uncertainty and health literacy
scores, the health literacy scores were transformed into quantiles for regression analysis.
Histograms in Figure 4 depicted normality in the distribution of MUIS-C scores and of
score residuals. Figure 5 shows the P-P Plot for distribution of residuals approximated
linearity. For the actual scores, skewness of .22 (SE = .27), kurtosis of -.42, (SE = .53),
and Shapiro Wilk test (p = .24) supported normality. Analysis of standardized residuals
with a skewness of .16 (SE = .27), kurtosis of -.54 (SE = .53) and Shapiro Wilk (p = .47)
also supported normality. The Levene’s test (F = .93, p = .604) suggested homogeneity
of variance. The profile plots of estimated marginal means for MUIS-C scores in Figure 6
had no intersecting lines suggesting no significant interactions between independent
variables.
Health literacy was not a significant predictor of uncertainty (Table 6). General
linear model testing revealed a significant corrected model (F(12, 69) = 3.23, p = .001),
with an adjusted R2 of .25 and ηp 2 = .360. A summary of findings in Table 6 shows that
accounting for age, gender, education, disease treatment phase, and health literacy, the
significant predictors of uncertainty are education (F(3, 69) = 6.36, p <.001, ηp 2 = .217),
and phase of care (F(3,69) = 6.52, p = .001, ηp 2 = .221).
Table 7 specifies the differences in levels of the categorical variables compared
with a reference in their groups. Within disease treatment phases, there was significant
difference in the uncertainty scores between those without surgery planned and those who
were within 2 years after surgery (B = -19.73; 95% CI = -31.14, -8.32; p = .001; ηp2 =
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.147). There was also a significant difference between those receiving treatment without
planned surgery when compared with those who were at greater than 2 years after
surgical resection (B= -26.66; 965% CI = -40.59, -12.74; p < .001; ηp2 = .175) and those
who were newly diagnosed but with potential for resection (B= -13.35; 965% CI = -2.42,
-24.35; p = .018; ηp2 = .078).
Within education levels, those whose highest attainment was completion of high
school had a significant difference in uncertainty scores compared with each of the other
education levels (Table 7). A significant difference was found between high school
graduates and those who went on to some college or vocational school (B = -18.71; 95%
CI = -28.07, -9.35; p < .001; ηp2 = .187). There was also a significant difference among
high school graduates and college graduates (B = -10.11; 95% CI = -19.34, -.87; p < .032;
ηp2 = .065) as well as high school graduates and those who attended or completed graduate
school (B = -16.18; 95% CI = -26.49, -5.86; p = .003; ηp2 = .124).
Predictors of Health Literacy
Histograms of the observed CHLT-30 scores and the standardized residuals using
general linear model revealed a non-normal distribution (Figure 7). The observed scores
had a skewness of -1.99 (SE = .27), kurtosis of 4.66 (SE= .53) and the Shapiro Wilk test
of .79 (p < .001) all indicating normality violation. The standardized residuals had a
skewness of .028 (SE = .27), kurtosis of 2.25 (SE= .53), and a Shapiro Wilk test of 82 (p
= .002) indicating non-normality as well. The P-P plot showed a curvilinear pattern
(Figure 8). Levene’s test at F = .865 (p = .633) actually indicated equality in error
variances. Given the negative skew of the observed scores, logarithmic transformation
was not effective. Exponential, square, and cube transformation did not provide
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appropriate correction. Multiple regression through general linear model was therefore
performed with bias corrected and accelerated bootstrapping (BCa) method set at 5,000
iterations with the final results generated by SPSS indicating 4969 test samples. The
profile plots of the estimated marginal means of the health literacy scores displayed no
transections but rather parallel lines suggesting no significant interaction between
independent variables (Figure 9).
The corrected model was significant (F(8, 73) =2.74, p = .011), with an adjusted
R2 of .15 and ηp 2 = .231. A summary of findings in Table 8 shows that accounting for
age, gender, education, and treatment phase, the significant predictors of health literacy is
education (F(3, 73) = 5.12, p = .003, ηp 2 = .174). Table 9 details the differences in the
levels of the categorical variables in comparison to a reference and shows the results of
bias estimates from bootstrapping along with BCa 95% confidence intervals and standard
errors with corresponding p values. Results of BCa in Table 9 show that those whose
highest attainment was completion of high school had a significant difference in health
literacy scores when compared to college graduates and those who attended or completed
graduate school. High school graduates and those who completed college had a
significant difference in health literacy scores without BCa at p = .003 (B = 3.60; 95% CI
= 1.28; 5.91; ηp2 = .116) and with BCa with p = .001 (BCa 95% CI = 1.82, 5.46; SE = .98;
bias estimate -.02). High school graduates and those who attended or completed graduate
school had a significant difference in health literacy scores without BCa at p = .001 (B =
4.53; 95% CI = 2.04; 7.02; ηp2 = .153) and with BCa with p < .001 (BCa 95% CI = 2.68,
6.55; SE = .98; bias estimate .03).
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Discussion
Uncertainty and Health Literacy
Based on the Uncertainty in Illness theory, the adapted model used for this study
(Figure 2) proposes health literacy as a structure provider that can frame unfamiliar,
incoherent, or destabilizing health experiences. It was hypothesized that the capacity to
obtain and process basic health information and services needed to make appropriate
health decisions has a significant inverse correlation with the cognitive inability to give
meaning to health-related events.
Uncertainty levels in this study tended to be lower in reference to values
summarized in the MUIS-C manual (N = 1068) with reported means of 42.4 – 85 and raw
scores between 23 and 155. The mean for this present study (M = 46.44, SD = 12.94)
approaches the lower end of the range reported in the manual. This is likely influenced
by the education characteristics of the present study participants that predispose towards
lower uncertainty. Health literacy scores trended higher in comparison with published
research on health literacy using the CHLT-30. A study on health literacy and
hospitalizations reported a CHLT-30 mean of 23.68 (SD = 5.52) (Cartwright, et al.,
2017). The validation study for the CHLT-30 involving 1,306 cancer patients reported
mean raw scores of 23.97 (SD=5.61) for men, 24.26 (SD=5.19) for women, 20.04
(SD=5.58) for non-Hispanic Blacks, and 26.61 (SD=3.38) for non-Hispanic Whites
(Dumenci, et al., 2014). These values are lower than the overall (Table 2) and
corresponding group mean scores (Table 4) from this study which is laden with
participants from demographic groups that predispose to higher health literacy.
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This study found a statistically significant correlation between uncertainty and
health literacy suggesting an inverse association where uncertainty tends to decrease as
health literacy increases. However, this was not a strong correlation (rs(81) = -.25, p =
.031). Although health literacy had a significant correlation with uncertainty, it actually
had a stronger significant correlation with education (rs (81) = .39, p < .001) which was a
significant predictor of uncertainty along with phase of care. The interplay between these
predictors likely factored in health literacy not maintaining its significance when
adjusting for other variables. Health literacy is multifaceted and some of its qualities and
effects may be shared with other variables thereby diminishing its individual influence in
the overall model. It is interesting to consider this in light of research by Howard,
Sentell, and Gazmararian (2006) in 3,260 participants to examine the extent to which low
health literacy exacerbates differences between education levels and racial groups with
respect to vaccination uptake and health status. Howard et al., found that health literacy
explained a small to moderate portion of the differences that would have been attributed
to education and race if health literacy were not considered (2006).
The results of this present study suggest while there is shared variance between
variables, both uncertainty and health literacy have distinct characteristics that are not
measured by other factors. Nonetheless, their interconnections merit further studies to
bear out their influence in the patient’s illness experience. The sample in the present
study is relatively small with an over-representation of participants from groups with high
literacy scores (White/Caucasians, higher levels of education attainment) and this
imbalance can potentially obscure otherwise significant relationships and effects on
uncertainty. Sample size and composition will be improved in future studies seeking to
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clarify associations and further evaluating a prediction relationship between health
literacy and uncertainty.
Effect of Education
Education level was found to be a significant predictor of uncertainty and health
literacy in support of study hypotheses. The finding pertaining to health literacy is in
accordance with a study on 402 smokers (Stewart, et. al, 2013) and with a study on 2,512
well-functioning older adults (Sudore, Mehta et al. 2006) that found low education level
to be a significant predictor of low health literacy. It is also consistent with the findings
of the landmark National Assessment of Adult Literacy whereby the US Department of
Education evaluated adult literacy involving 19,000 participants (US Department of
Education, 2006) that found average health literacy increased with each higher level of
education attainment. The significant finding that education is a predictor of uncertainty
is consistent with the summary in the MUIS-C manual that reports uncertainty scores
decrease as education level increases (Mishel, 1997).
Education level was significant for MUIS-C and CHLT-30 in both Kruskal Wallis
and general linear model testing. Education level is a predictor that suggests those whose
highest attainment is high school completion have higher uncertainty and lower health
literacy compared with participants at every other level of education attainment.
This study sample had 72 (87%) participants with post-high school education and
43 (52.4%) with a bachelor’s degree or higher. For reference, only 33% of adults in the
United States hold a bachelor’s degree or higher (U.S. Department of Commerce, 2015).
With this education composition, this study sample trended towards lower uncertainty
scores and higher health literacy scores. This has practical value in helping identify
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patients at risk for requiring special guidance in understanding their illness and engaging
in their treatment decisions.
The study results also highlight the importance of distinguishing between
education and health literacy and given the tendency to sometimes attribute health
literacy levels based on education level, this underscores the importance of examining the
unique aspects of each variable.
Effect of Race/Ethnicity
Race/Ethnicity was evaluated as a predictor but inferences and generalizability are
restricted by the study sample comprising predominantly of White/Caucasian
participants. According to the National Institutes of Health, the incidence of pancreatic
cancer per 100,000 persons is 17 and 14.3 in Black/African males and females
respectively compared with 14.2 and 11 in White males and females (National Institutes
of Health, 2018). This highlights the need to conduct future research in settings that will
allow for adequate representation of the diverse groups affected by this disease.
Phase of Care and Uncertainty
Disease treatment phase was a significant predictor of uncertainty in this study.
Although pancreas cancer patients report frequent concerns about unpredictability of
disease recurrence following treatment completion (Petzel, et al., 2013), uncertainty
trended lower in patients who were further away from the time of their surgical resection
compared with those who were closer to initial diagnosis. This is consistent with
findings on evaluation of uncertainty predictors in brain tumor patients (Lin et al., 2015)
where higher levels of uncertainty were found in patients closer to initial diagnosis.
Pancreatic cancer patients in this study who were yet to undergo surgery had higher
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uncertainty levels likely owing to the complexity and newness of the disease experience
along with the concern that surgery may become a non-viable option if disease progresses
or metastasis develops while on pre-operative treatment. However, patients who were
close to initial diagnosis but determined to have unresectable disease and ineligible for
curative resection had the highest levels of uncertainty. Surgical resection is the only
treatment that bears potential for cure and being ineligible for curative treatment could
predispose patients to a sense of disorganization and instability. The complexity of endof-life concerns can also heighten uncertainty. Although patients who are receiving presurgery treatment are not guaranteed surgery, the possibility and hope for cure may be a
mitigating factor for uncertainty. These findings are consistent with the Uncertainty of
Illness theory that describes patient’s cognitive appraisal of events as a danger or an
opportunity (Figure 1). Uncertainty can diminish if uncertain situations have potentially
favorable outcomes while threatening outcomes can amplify uncertainty (Mishel, 1990).
It was hypothesized that disease treatment phase would also have a significant
influence on health literacy as the ability to access, understand, and utilize information
could improve with more exposure to health information and services during the course
of the care and treatment. This was not supported by the study but merits further
evaluation with a larger sample that better represents heterogeneity in disease phases. A
longitudinal study with repeat testing at the different phases can also be considered to
find patterns of change while tracking the same patients for differences in health literacy
levels through their disease course.
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Technology Utilization
A majority of patients in this study reported owning a mobile phone that they used
for purposes other than phone calls and also reported using the electronic health record
system. This can also influence the mode of instrument administration in future studies
with utilization of tablet or electronic administration instead of using pen and paper. The
association of technology proficiency and health literacy can also be formally
investigated in future studies.
Strengths and Limitations
This is the first study on uncertainty and health literacy focusing on pancreatic
cancer patients. The study was conducted in a single-institution with participants who are
predominantly White/Caucasian, mostly well-educated, married, and predominantly in
the pre-surgical phase of treatment. The study generated valuable information but its
homogenous sample restricts inferences and extrapolations especially with respect to
effects of race/ethnicity. The high health literacy and low uncertainty levels in this
sample may denote self-selection bias as participants with proficiency and resources that
facilitate successful navigation of pathways towards receiving care in specialized centers
may not be predisposed to high uncertainty or low health literacy. However, the small
sample size may have also obscured significant relationships and effects that need larger
samples to clarify.
The health literacy instrument was noteworthy. The CHLT-30 has advantages in
that it is tailored for cancer patients across the health literacy continuum and is reliable
and well-validated. Rather than merely screening for low health literacy or measuring the
patient’s perception of their health literacy, CHLT-30 actually measures knowledge,
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skills, as well as confidence about engaging in health decisions. In doing so, the CHLT30 can be lengthy with a degree of difficulty that can lead to bias as patients who are not
confident with knowledge or test skills, and patients who are feeling poorly are more apt
to defer or decline. Instruments that are highly reliable and well validated are critical but
length of administration time and suitability to location and setting need consideration.
In a high-volume and busy setting that involve an interdisciplinary team managing a
highly-complex patient population, options should be carefully considered against
research objectives. Future studies in similar settings should consider briefer
instruments. Moreover, with the suggestion that patients in this setting have a high
degree of technology utilization, electronic administration should be considered in future
studies.
Despite the small sample size and lack of generalizability especially with respect
to race/ethnicity, this study generated constructive follow-up research questions and
provided useful information on identifying patients who require support with
understanding their illness experience and those who require guidance with accessing
information and services.
Summary and Future Directions
In conclusion, the present study describes valuable information on uncertainty and
health literacy in pancreatic cancer patients as well as potential predictors. The data
supported an inverse relationship between the uncertainty and health literacy but did not
support health literacy as a significant predictor for uncertainty when accounting for other
variables. The findings were consistent with prior research in showing that education
level is a significant predictor for both uncertainty and health literacy. Moreover, the
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study findings indicated support for disease treatment phase being a predictor for
uncertainty.
Further research is needed to delineate the effects of education, race, and health
literacy on uncertainty. Variables that mitigate uncertainty but disfavors enhancement of
health literacy or vice versa also need to be studied. The effect of race and ethnicity need
additional investigation as the race/ethnic composition of this sample limits extrapolation.
Future studies will require larger sample sizes with adequate representation of
demographic and clinical groups in order to uncover and clarify significant relationships
that will help patients understand their illness experience and enhance knowledge, skills,
as well as access to information and services.
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Table 1
Demographic Characteristics
Demographic Characteristic

MUIS-C AND CHLT-30
N = 82
n (%)

Age (mean) (range)
Gender
 Male
 Female
Marital Status
 Married
 Single
 Widowed
 Married; currently separated
 Unmarried; with significant other
Racial and Ethnic Self-Identification
 Asian
 Black, African-American
 Latino, Hispanic
 White, Caucasian
 Native American
 Native Hawaiian, Pacific Islander
Level of Education
 Some High School
 Completed High School
 Vocational School
 Some College
 Completed College
 Some Graduate School
 Complete Graduate Degree
Phase of Care
 Before Surgery
 Within 2 Years After Surgery
 Within 5 Years After Surgery
 5 or More Years After Surgery
 No Surgery Planned
Do you have cellular phone?
 Yes
 No
Do you use cellular phone for purposes other than calls?
 Yes
 No
Do you use electronic health record to access your medical
information?
 Yes
 No

64.59 (50)
45 (55%)
37 (45%)
61 (74%)
8 (10%)
9 (11%)
1 (1%)
3 (4%)
4 (5%)
7 (8%)
6 (7%)
65 (79%)
10 (12%)
3 (4%)
26 (32%)
27 (33%)
4 (5%)
12 (15%)
40 (49%)
30 (37%)
5 (6%)
2 (2%)
5 (6%)
81 (99%)
1 (1%)
78 (95%)
4 (5%)

76 (93%)
6 (7%)

Note. MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = Cancer
Health Literacy Test.
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Table 2
MUIS-C and CHLT-30 Descriptive Statistics
MUIS-C Scores
N

Valid
Missing

Mean
Std. Error of Mean
95% CI
Lower
Upper
Median
Std. Deviation
Range
Minimum
Maximum
IQR
Skewness
Kurtosis

82
0
46.46
1.43
43.62
49.28
46.5
12.938
60
23
83
21
.22 (SE = .27)
-.42 (SE = .53)

CHLT-30
82
0
26.65
.365
25.95
27.37
28.00
3.301
16
14
30
4
-1.99 (SE =. 27)
4.65 (SE =.53)

Note. MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = Cancer
Health Literacy Test 30; SE = standard error; CI = confidence interval; IQR = interquartile range.

Table 3
MUIS-C Results by Groups
Demographic Characteristic
Gender
 Male
 Female
Marital Status
 Married
 Single
 Widowed
 Married; currently separated
 Unmarried; w/ significant other
Racial, Ethnic Self-Identification
 Asian
 Black, African-American
 Hispanic
 White, Caucasian
Level of Education
 Completed High School
 Vocational School
 Some College
 Completed College
 Some Graduate School
 Complete Graduate Degree
Phase of Care
 Before Surgery
 Within 2 Years After Surgery
 Within 5 Years After Surgery
 5 or More Years After Surgery
 No Surgery Planned

n

Mean

SD

95% CI

Min

Max

Median

IQR

P value
(H = .17; p =.678)

45
37

47.07
45.73

12.98
12.99

43.17 - 50.97
41.4 – 50.06

25
23

83
74

47
46

21
21

61
8
9
1
3

45.72
52.5
47.89
45.69
44.33

12.48
17.96
13.33

42.52 - 48.92
37.48 - 67.52
37.64 – 58.13

23
25
26

70
83
74

46
53
51

24
26
14

5.03

31.83 – 56.84

39

49

45

.

4
7
6
65

44.50
56.14
36.5
46.46

6.25
7.73
9.27
13.32

34.56 – 54.44
48.99 – 63.3
26.77 – 46.23
43.16 – 49.76

37
48
26
23

52
70
50
83

44.5
54
36
46

12
11
16
22

10
3
26
27
4
12

59
34.67
44.19
47.89
34
44.83

14.20
10.26
12.65
11.02
5.29
11.38

48.84 – 69.16
9.17 – 60.16
39.08 – 49.30
43.53 – 52.25
25.58 – 42.42
37.61 – 52.06

31
26
23
27
27
25

83
46
70
67
39
65

56.5
32
45
48
35
43

17
.
22
20
10
16

40
30
5
2
5

49.08
42.57
40
39
58.4

12.69
12.54
9.43
18.38
8.26

44.97 – 53.08
37.88 – 47.25
28.29 – 51.71
-126.18 – 204.18
48.14 – 68.66

27
23
31
26
50

83
67
56
52
70

49.5
42
37
39
59

17
20
14
.
16

(H = 1.72; p =.787)

(H = 8.39; p =.039)

(H = 15.44; =.009)

(H = 10.70; p =.030)

Note. P values generated using Kruskal Wallis analysis, H values represent Kruskal Wallis statistics. MUIS-C = Mishel Uncertainty in
Illness Scale –Community. n = sample size, SD = standard deviation; CI = confidence interval; Min = lowest score; Max = highest
score; IQR = inter-quartile range; H = Kruskal Wallis test statistic; Significance p < 0.05
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Table 4
CHLT-30 Results by Groups
Demographic Characteristic
Gender



Male
Female

N

Mean

SD

95% CI

Min

Max

Median

IQR

45
37

26.4
26.95

3.16
3.48

25.45 – 27.35
25.79 – 28.11

14
14

30
30

27
28

4
3
(H = 8.90; p =.063)

Marital Status


Married

Single

Widowed

Married; currently separated

Unmarried w/ significant other
Racial and Ethnic Self-Identification

P value

(H = 1.94; p =.164)

61
8
9
1
3

27.02
24
26
29
27.33

3.01
3.07
4.87

26.25 - 27.79
21.43 – 26.57
22.25 – 29.75

14
19
14

30
28
30

28
25
28

3
5
4

2.08

22.16 – 32.50

25

29

28

4


Asian

Black, African-American

Hispanic

White, Caucasian
Level of Education

Completed High School

Vocational School

Some College

Completed College

Some Graduate School

Complete Graduate Degree
Phase of Care

4
7
6
65

26.25
21.71
24.17
27.43

2.22
7.09
3.55
2.00

22.72 – 29.78
15.16 – 28.27
20.45 – 27.89
26.94 – 27.93

24
25
18
21

29
30
28
30

26
19
24.5
28

4
15
6
3

10
3
26
27
4
12

23.6
27.67
25.88
27.52
29.00
27.83

2.72
.57
4.63
1.63
.82
1.85

21.66 – 25.54
26.23 – 29.10
24.01 – 27.76
26.88 – 28.16
27.7 – 30.30
26.66 – 29.01

18
27
14
25
28
24

27
28
30
30
30
30

24
28
28
28
29
28

4
1
4
3
2
2






Before Surgery
Within 2 Years After Surgery
Within 5 Years After Surgery
5 or More Years After Surgery

40
30
5
2

25.95
27.57
26.80
28

4.06
1.87
2.39
.

24.65 – 27.25
26.87 – 28.26
23.84 – 29.76
.

14
24
23
28

30
30
29
28

27.50
28
28
28

5
3
4
.



No Surgery Planned

5

26

4.06

20.96 – 31.04

19

29

28

6

(H = 9.19; p =.027)

(H = 18.33; p = .003)

(H = 1.97; p =.580)
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Note. P values generated using Kruskal Wallis analysis, H values represent Kruskal Wallis statistics. CHLT-30 = Cancer Health
Literacy Test 30; n = sample size, SD = standard deviation; CI = confidence interval; Min = lowest score; Max = highest score; IQR
= inter-quartile range; H = Kruskal Wallis test statistic; significance p < 0.05

Table 5
Levels Within Predictor Categories with Significant Differences on Kruskal Wallis Testing
H

SE

Std. Test
Statistic

Sig

Adj. Sig

MUIS-C SCORES
EDUCATION
 Completed HS/ Some Grad School

44.16

14.08

31.26

.002

.026

38.06

13.24

2.87

.004

.024

RACE
 Latino – Black
PHASE OF CARE *

CHLT-30 SCORES
RACE*
EDUCATION
 Completed HS/Some College

-25.82

8.76

-2.95

.003

.048

 Completed HS/Completed College

-29.75

8.71

-2.42

.001

.010

 Completed HS/Some Grad School

-49.20

13.92

-3.54

.000

.006

 Completed HS/Completed Grad School

-34.41

10.07

-3.42

.001

.010
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Note. * Variable was significant on Kruskall Wallis analysis but post-hoc testing did not reveal differences Post-hoc pair-wise testing
was performed on all variables. Table only includes information on the pairs with significant differences; . CHLT-30 = Cancer
Health Literacy Test 30; MUIS-C = Mishel Uncertainty in Illness Scale –Community; H = Kruskal Wallis test statistic; SE = standard
error; Std = standardized; Adj. Sig = Bonferroni adjusted; Sig = p < .05

Table 6
General Linear Model Tests of Between Subjects – Effects with MUIS-C as Dependent Variable

Type III Sum of
Squares

df

F

Sig.

Partial Eta
Squared

Corrected Model

4865.51

12

3.23

.001

.360

Intercept

3507.30

1

27.96

.000

.289

EDUCATION

2395.09

3

6.36

.001

.217

PHASECARE

2453.72

3

6.52

.001

.221

SEXGENDER

.01

1

.00

.993

.000

AGE

4.46

1

.04

.851

.001

CHLT-30

97.66

4

.20

.940

.011

Error

8656.88

69

Total

190548.00

82

Corrected Total

13522.39

81

R Squared = .360 (Adjusted R Squared = .25)
Note. df = degrees of freedom; MUIS-C = Mishel Uncertainty in Illness; Scale –Community;
CHLT-30 = Cancer Health Literacy Test 30
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Table 7
General Linear Model Significant Differences in MUIS-C Scores Within Independent Variables
Corrected Model Summary

Adjusted R2
.248

F (df)
3.23 (12,69)

Sig.
p = <.001

Partial Eta
Squared
ηp2 = .360

Significant Differences in MUIS-C Scores Within Independent Variables

B
Highest Education Attainment
Completed High School
Vocational/Some College
(Reference)
Completed College
Some or Completed Grad
School
Gender
Female (Reference)
Male
Disease Treatment Phase
No Surgery Planned
Before
Surgery
(Reference)
Within 2 years After Surg
Greater 2 years from Surg
CHLT-30 SCORE
CHLT -30 Score 30
CHLT-30 Score 14 -25
CHLT -30 Score 26-27
CHLT -30 Score 28
CHLT -30 Score 29
AGE

95% Confidence Interval
Lower Bound Upper Bound

t

SE

p

ηp2

-18.71
-10.11
-16.18

4.69
4.63
5.17

-3.99
-2.18
-3.13

-28.07
-19.34
-26.49

-9.35
-.87
-5.86

.000
.032
.003

.187
.065
.124

.011

2.73

.00

-5.44

5.46

.997

.000

-13.35
-19.73
-26.66

5.52
5.72
7.00

-2.42
-3.45
-3.82

-24.35
-31.14
-40.59

-2.35
-8.32
-12.74

.018
.001
.000

.078
.147
.175

1.14
-1.21
.21
-1.94
.03

4.92
5.01
5.00
4.81
.14

.23
-.24
.04
-.40
.19

-8.68
-11.19
-9.76
-11.53
-.24

10.95
8.80
10.18
7.66
.29

.818
.812
.967
.688
.851

.001
.001
.000
.002
.001

81

Note. df = degrees of freedom; B = unstandardized coefficient; ηp2 = partial eta squared; Sig = significance; p < .05
MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 = Cancer Health Literacy Test

Table 8
General Linear Model Tests of Between Subjects – Effects with CHLT-30 as Dependent Variable
Type III Sum
of Squares
204.01

df
8

F
2.74

Sig.
.011

Partial Eta
Squared
.231

1099.63

1

118.27

.000

.618

EDUCATION

142.84

3

5.12

.003

.174

PHASECARE

27.11

3

.97

.411

.038

SEXGENDER

11.68

1

1.26

.266

.017

AGE

6.82

1

.73

.395

.010

Error

678.73

73

Total

59105.00

82

Corrected Total

882.74

81

Source
Corrected
Model
Intercept

R2 = .23; Adjusted R2 - .15

Note. df = degrees of freedom; B = unstandardized coefficient; ηp2 = partial eta squared; Sig = significance; p < .05
CHLT-30 = Cancer Health Literacy Test 30
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Table 9
General Linear Model Significant Differences in CHLT-30 Scores Within Independent Variables
Corrected Model Summary
Adjusted R2

Bootstrap Results

Type II Sum of Squares

F (df)

Sig.

Partial Eta
Squared

.15
204.01
2.74 (8,73)
p = <.011
Differences in CHLT-30 Scores Within Independent Variables
95%
Confidence
IntervalUpper
Lower
Bound Bound

SE

t

1.18

1.96

-.04

4.67

1.16

3.09

1.28

4.53

1.25
Gender

3.63

-.81

.72

-1.12

B

ηp2 = .231

BCa 95%
Confidence
Interval Upper
Lower
Bound
Bound

ηp2

Bias

SE

P

.054

.050

.01

1.32

.095

-.36

4.91

5.91

.003

.116

-.02

.98

.001

1.82

5.46

2.04

7.02

.001

.153

.03

.98

.000

2.68

6.55

-2.25

.63

.266

.017

-.04

.79

.315

-2.42

.57

-3.23

2.73

.867

.000

.003

2.19

.918

-3.67

4.09

-2.13

4.00

.544

.005

.03

2.08

.665

-2.23

5.23

-2.70

4.78

.582

.004

.03

2.18

.631

-2.45

5.53

p

Highest Level of Educational Attainment
Completed High School (Reference)
Vocational/Some College
2.31
Completed College
3.60
Some/Completed Grad School

Female (Reference)
Male

No Surgery Planned (Reference)
Before Surgery
Within 2 years After Surgery
2 years After Surgery

Phase of Care/Treatment
.
.
-.25
1.50
-.17
.
.94
1.54
.61
.
1.04
1.88
.55
.
.
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Note. Bias corrected and accelerated bootstrap calculation was set at 5,000 iterations with SPSS generating results based on 4969
samples. df = degrees of freedom; B = unstandardized coefficient; ηp2 = partial eta squared; Sig = significance; p < .05

Figure1. Mishel’s Uncertainty in Illness Model. Adapted from Uncertainty in Illness (Mishel, 1998)
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Figure 2. Antecedents to Uncertainty in Illness. Adapted from Uncertainty in Illness (Mishel, 1998)
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Figure 3. Scatterplot for MUIS-C and CHLT-30 Scores. MUIS-C = Mishel Uncertainty in Illness Scale –Community; CHLT-30 =
Cancer Health Literacy Test 30
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A

B

Figure 4. Histogram of MUIS-C observed scores and Histogram of MUIS-C Standardized Residuals. A = histogram of MUIS-C raw
scores; B = histogram of MUIS-C standardized residuals. MUIS-C = Mishel Uncertainty in Illness Scale –Community
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Figure 5. P-P Plot of Standardized Residuals for MUIS-C Scores. Probability plot of MUIS-C standardized residuals; MUIS-C =
Mishel Uncertainty in Illness Scale –Community.
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Figure 6. Estimated Marginal Means Profile Plots for MUIS-C. Covariates appearing in the model are evaluated at the following
values: AGE = 64.59, chlt30_score = 26.65. No intersecting lines suggesting interaction were noted.
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A

B

Figure 7. Histogram of CHLT-30 observed scores and Histogram of CHLT-30 Standardized Residuals. A = histogram of CHLT-30
raw scores; B = histogram of CHLT-30 standardized residuals. CHLT-30 = Cancer Health Literacy Test

90

Figure 8. P-P Plot of Standardized Residuals for CHLT-30 Scores. Probability plot of standardized CLHT-30 residuals
CHLT-30 = Cancer Health Literacy Test
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Figure 9. Estimated Marginal Means Profile Plots for CHLT-30. Covariates appearing in the model are evaluated at the following
values: AGE = 64.59. No intersecting lines suggesting interaction were noted.

92

93

Appendix A
Approval of Proposal by Dissertation Committee (D2 Form)

94

95

Appendix B
UT M.D. Anderson Cancer Center Approval from
Institutional Review Board

96

97

98

99

Appendix C
The University of Texas Health Science Center at Houston
Approval from the Committee on the Protection of Human Subjects

100

101

Appendix D
Protocol and IRB-Approved Amendments
MD Anderson Cancer Center Protocol 2017-0011

102

2017-0011
March 27, 2017

Uncertainty and Health Literacy In Pancreatic Cancer Patients
Study Chair: Rae Brana Reynolds, RN, ANP,
Department: Surgical Oncology
Phone: 713-792-6940
Unit: 1484

103

1.0 Objectives
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel
Uncertainty in Illness Scale – Community instrument (MUIS-C)
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its
association to uncertainty in the pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower
levels of uncertainty in pancreatic cancer patients
Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic
cancer patients after adjusting for age, sex, race, education level, and disease treatment
stage
3. Examine if age, sex, race, education level, and disease treatment stage are significant
predictors of uncertainty and health literacy in the pancreatic cancer population
Hypothesis 3a: Education level, race, disease treatment stage are significant predictors
of uncertainty and of health literacy in pancreatic cancer patients
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of health
literacy in pancreatic cancer patients
The primary aim is to determine if a significant correlation exists between of uncertainty
and health literacy in the pancreatic cancer population (hypothesis 2a). As neither
uncertainty nor health literacy has been studied in this population, exploratory aims are to
describe uncertainty and health literacy in pancreatic cancer patients, and to examine for
significant predictors.
2.0 Rationale
Pancreatic cancer has aggressive biology, vague and distressing symptoms, and lacks
expert agreement on treatment guidelines for patients with potentially-curable, resectable
disease. For patients undergoing treatment, there is debate even among experts regarding
the sequence of therapy for patients with resectable disease (Evans et al., 2008;
Varadhachary et al., 2008). The National Comprehensive Cancer Network (NCCI)
recommends upfront surgery for potentially-resectable pancreatic cancer but expert
consensus and a number of phase II clinical trials support administration of neoadjuvant
chemotherapy in selected patients with biopsy-proven carcinoma prior to surgery
(Halperin & Varadhachary, 2014). Even for patients who complete treatment, the
widely-acknowledged high recurrence rate undermines confidence in having achieved
long-term survival or cure. The 5-year survival rate for pancreatic cancer remains low at
7% (ACS, 2016) and approximately 80% of patients undergoing resection with curative
intent develop distant metastasis or local recurrence within five years of surgery
(Halperin & Varadhachary, 2014). With a grim prognosis, patients can become overly
vigilant and mistakenly interpret symptoms unrelated to malignancy as indications of
disease recurrence. All of these factors contribute to uncertainty, defined as a cognitive
state wherein there is inability to give meaning to illness events (Mishel, 1988, Mishel &
Braden, 1988, Mishel, et al., 2009). ). It is conceptualized by Mishel within the
Uncertainty of Illness Theory as a cognitive state that occurs when the decision maker
unable to assign values to events or is unable to predict outcomes due to cues being
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lacking or insufficient (Bailey, et al., 2011). The framework describes that individuals
cognitively process illness stimuli then through primary appraisal, derive meaning.
Uncertainty has been studied in many cancer populations (Bailey et al., 2011; Cahill et
al., 2014; Elphee, 2008; Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002;
Mishel et al., 2009; Parker et al., 2013) but it has not been studied in pancreatic cancer
patients.
Uncertainty is linked to poor outcomes (Lin et al., 2015) and one factor that can
potentially mitigate uncertainty is health literacy, defined as the capacity to obtain,
process, and understand health information and services needed to make appropriate
health decisions (Dumenci, 2014). Limited health literacy is also associated with
unfavorable outcomes in cancer patients (Mahal, 2015; Busch, 2015: Winton, 2016;
Hawley, 2008; Koay, 2013) and low health literacy is perceived by cancer patients as a
barrier to good outcomes (Rust, 2011; Rust, 2012). Unfortunately, health literacy has not
been studied either with a focus on pancreatic cancer patients whose illness experience
require navigation of complex information and services pathways in order to engage
successfully in treatment decisions.
Despite the shared link to information processing suggested by their definitions, the
relationship between uncertainty and health literacy has not been studied in cancer
patients and has not been studied individually in pancreatic cancer patients. This study
planned within a framework adapted from Mishel Uncertainty Theory will address these
gaps (Mishel, 1988, Mishel & Braden, 1988, Mishel, et al., 2009). The model adapted
from MIshel’s orginal framework and focused on the antecedent portion of the original
model is illustrated in Figure 1.

Figure 1. Antecendents of Uncertainty in Pancreatic Cancer Patients
Adapted from Mishel’s Uncertainty in Illness Theory (Mishel, 1988).
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In this model, Event Stimuli represents the events during the different phases of diagnosis
and disease management that the patients may experience. The Structure Providers
represent factors that can help the patient interpret illness events. Patient Characteristics
include the patient’s demographics that include age, education level, sex, and race.
The study will examine demographic and factors to evaluate if there are predictors that
can guide future research and identification of individuals who are more susceptible to
uncertainty. Prior health literacy assessment in 1,306 cancer patients found no significant
mean difference between men and women (p=.247) but the scores among African
Americans were found to be significantly lower (p < .0001) than White participants
(Dumenci et al., 2014). This study found that participants with limited health literacy
consisted of an overrepresentation of African-Americans, patients who were
undereducated, and patients with lower income (Dumenci et al., 2014). Meanwhile
aggregate data on different population subgroups described in the Uncertainty in Illness
Scales Manual indicate no difference in the mean scores based on sex or age but that
scores decrease with an increase in level of education (Mishel, 1997). These
demographic variables will be evaluated as this can influence the design and
implementation of future studies and intended population of intervention programs.
Moreover, patient uncertainty has been found to vary according to disease treatment stage
with a brain tumor population study showing variation depending on treatment status
with newly diagnosed patients and patients on active treatment having high levels of
uncertainty (Lin et al., 2015). This will be assessed in pancreatic cancer patients to
facilitate and promote communication between clinicians and patients when making
health care decisions.
3.0 Eligibility of Subjects
INCLUSION CRITERIA
1. Patients with a diagnosis of biopsy-proven pancreatic adenocarcinoma who are
being treated in an Ambulatory Outpatient Clinic at MD Anderson Cancer Center
Main Campus.
2. Patients who meet the above criteria and are 18 years of age or older
EXCLUSION CRITETRIA
1. Patients who have a history or current diagnosis of another primary malignancy
other than pancreatic adenocarcinoma
2. Patients unable to speak, read, or write in English will be excluded because the
study instruments are in English
3. Pancreatic adenocarcinoma patients who are under 18 years of age
4.0 Research Plan and Methods
The study is designed as an observational, cross-sectional study seeking to describe
uncertainty in illness and health literacy in the pancreatic cancer population and explore
the relationship between these variables. Given the absence of prior studies on
uncertainty and health literacy in pancreatic cancer patients, this design is appropriate as
an exploration that can provide groundwork for future research. Written approval prior

106

to the initiation of the study will be obtained from the Institutional review Board of MD
Anderson. The principal investigator (PI) will provide training to study staff prior to data
collection.
Recruitment:
Patients who meet the eligibility criteria will be invited to participate in the study when
they present for a clinic visit by the investigator and will be approached to obtain
informed consent. This study and the recruitment will be conducted in the outpatient
clinic during a patient’s scheduled visit to the clinic. Patients will not be required to
report to clinic for the purpose of study participation on days when they otherwise do
not have a scheduled visit for cancer treatment or follow-up.
Collaboration and coordination with the clinic team seeing the patients will be
established for the study prior to beginning screening, recruitment, and enrollment. The
eligibility review and recruitment will be as follows:
1. Primary investigator will pre-screen the patients scheduled to attend pancreatic
cancer clinic in preparation for the research study
2. Primary investigator will send the list of eligible patients to the clinic team and
obtain permission to recruit the patients in clinic on the day of their visits
3. Primary investigator will approach the eligible patients in clinic on a consecutive
basis to explain the study and invite their participation
4. The primary investigator will explain the Informed Consent process and voluntary
nature of study participation and address patient questions
5. The principal investigator will obtain signatures for Informed Consent
6. A copy of the completed consent will be kept in the electronic health record
system
7. A copy of the completed consent will be offered to the patient and given to those
who want to keep a copy for their personal records

Registration:
Enrolled patients will be registered into the Clinical Oncology Research System (CORe)
which serves as the MD Anderson Cancer Center institutional patient data management
system.
Data Collection:
The questionnaires will not contain identifiers but will only have a participant number.
Enrolled patients will complete the instruments in the clinic. Collaboration and
coordination with the clinic team seeing the patients will be established for the study prior
to beginning screening, recruitment, and enrollment.
The participants will complete the questionnaires in the clinic room or waiting area before
they are seen by the physician during their visit.
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1. Data will be collected by paper and pencil surveys with the investigator entering
information into the web-based REDCap application hosted by MD Anderson
Cancer Center (https://redcap.mdanderson.org)
2. The investigator or a clinical research staff will be available in clinic during the
time the patient is completing the instruments
3. The investigator or research staff may not provide any answers to the specific
questions on the questionnaire but can address questions about study participation
or the process of form completion
4. Only the patient may complete the form. Family members or patient companions
to the visit may not answer or complete the forms. If there are deficits that makes
reading the questionnaire or writing the responses difficult, the questionnaire can
be read to the patient by the research staff or the patient companion and the
responses recorded according to the patient response
5. Investigator or research staff will review the forms to ensure completeness or that
the participant has responded to all the items that want to answer. The primary
investigator will keep the completed forms to a secure location in the primary
investigator’s office
6. Participants will not take home their questionnaires for completion. If a
participant does not complete his or her participation while in clinic, the
participant will not be included in the sample to be analyzed.
Recruitment and informed consents is anticipated to take 20 minutes while the time to
complete the instruments is anticipated to take approximately 20 minutes with a total
participation time of 40 minutes. The primary investigator will enter the data into the
secure RedCap database. Data entry and instrument scoring will be conducted according
to the instrument manuals and study protocol prepared for the study.
INSTRUMENTS
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be used to
measure uncertainty. The MUIS-C has 23 items scored 1 to 5 on a Likert scale. The item
scores are summed with a higher cumulative score indicating greater uncertainty. The
MUIS-C has been used extensively with cancer patients. The MUIS-C was adapted from
the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally developed to
evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 2011). Items from
the MUIS-A specifically relating to inpatient hospitalization were removed and the
remaining questions comprise the items for the MUIS-C version. The MUIS-A was
developed through expert analysis and validation of the MUIS-A was utilized to support
the validity of the MUIS-C (Bailey et al., 2011). In analyses of MUIS-C scores from 18
samples of chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a
large majority of the samples indicating the reliability of MUIS-C as comparable to the
0.87 reported for the MUIS-A (Bailey et al., 2011). Scores can range from 23 to 115
with a higher score indicating higher uncertainty. There is no categorical delineation
regarding what is considered as “low”, “moderate” or “high” uncertainty.
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The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be used to
measure health literacy. The 30-item CHLT-30 was created to assess literacy along the
cancer health literacy continuum. Its development was described in a publication of a
study involving 1,306 adults with heterogenous cancer diagnoses, educational attainment,
and health insurance and marital status. Pancreatic cancer was not listed as a category
among the 11 diagnostic cancer types represented by the participants in the study sample.
The reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of
0.90. There was support for the unidimensional scale and all variables had significant
factor loadings of > 0.44. Structural equation modeling supported external validity with
self-confidence in engaging in health decisions specified as a latent variable measured by
two positively and two negatively worded items. The test score is the total number of
correct responses and ranges from 0 to 30. The instrument response time ranges from 1015 minutes (Dumenci, et. al., 2014).
A Patient Demographic Form will be utilized to record demographic information
including age, sex, education level, race, and disease treatment stage.
5.0 Statistics and Justification of Sample Size
The sample size calculation is based on the primary aim to determine a correlation
between uncertainty and health literacy. An estimated total of up to 91 patients will be
invited to participate. With an anticipated response rate of approximately 90%, an
analyzable sample size of 82 will be produced. The primary objective is to collect the
uncertainty and health literacy information in pancreatic cancer patients and assess the
correlation between uncertainty and health literacy. The primary endpoints are the
Mishel uncertainty scores, which is defined as the summation of all the questions
scores and the cancer health literacy test scores which is defined as the number of
questions that the patient answers correctly. With 82 patients in total, given the twosided type I error of 5%, we will have an 80% power to detect a Pearson’s correlation
of 0.3 between uncertainty score and cancer health literacy score. nQuery/nTerim
version 3.0 was used for the sample size justification.
Questionnaire scores will be calculated based on standardized manuals associated with
each survey instrument. Descriptive statistics will be used to summarize scores of the
questionnaires according to respective scoring manuals for each of the measures. The
distribution of each continuous variable will be summarized by its mean, standard
deviation, median, and range. The distribution of each categorical variable will be
summarized in terms of its frequencies and percentages. The difference in uncertainty
and health literacy scores will be assessed between groups (e.g. gender, education
levels) by a two-sample t-test or ANOVA if the data is normally distributed; otherwise
a Wilcoxon rank sum or Kruskal-Wallis test will be used. The association between
uncertainty scores and health literacy score will be examined by Pearson correlation.
To identify factors associated with uncertainty or health literacy scores of the survey
measures, for example, the patient education level, age, race, and gender, multivariate
linear regression will be performed to examine their effects.
Specifically, the hypotheses testing and anticipated results are as follows:
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1.

Describe uncertainty in the pancreatic cancer patient population using the MUIS this primary, exploratory aim will assessed using Descriptive Analysis and Analysis
of Variance (ANOVA)

2.

Describe health literacy using the CHLT-30 and its association to uncertainty in the
pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with
lower levels of uncertainty in pancreatic cancer patients - Pearson product
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho
will be used if there is not a linear relationship or normal distribution. The
anticipated result will be an inverse linear association between uncertainty and
health literacy.
Hypothesis 2b: Health literacy is an independent significant predictor of
uncertainty in pancreatic cancer patients after adjusting for age, sex, education
level, race, disease treatment stage - Health literacy will be included in
multivariate regression to evaluate if it is a significant predictor of uncertainty after
adjusting for other variables under study.

3.

Examine significant demographic predictors of uncertainty and health literacy in the
pancreatic cancer population
Hypothesis 3a: Education level, race, disease treatment stage are significant
predictors of uncertainty and of health literacy in pancreatic cancer patients –
Multiple linear regression will be performed to determine if these variables are
significant predictors for uncertainty and multivariate regression will be also be
performed to assess if they are significant predictors for health literacy as well. The
anticipated results will be that education level, race, and disease treatment stage will
be significant predictors for both health literacy and uncertainty.
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of
health literacy in pancreatic cancer patients - Multivariate regression will be
performed to determine if age and sex are significant predictors for uncertainty and
multivariate regression will be also be performed assess if they are significant
predictors for health literacy as well. The anticipated results will be that neither age
not sex will come out as significant predictors for either uncertainty or health
literacy.

6.0 Informed Consent Process
Participants 18 years of age and older will be consented in the clinic during scheduled
visits. They will be consented by the study PI or by authorized, trained research personnel
listed on the Delegation of Authority. This study has minimal risks and does not provide
treatment.
Patients will be given the opportunity to review study documents and ask questions, and
will be given time to consider their participation prior to signing the consent. This study
is limited to English-speaking patients, due to the instruments only being available in
English, therefore, patients who are unable to read, write, and understand English will not
be consented to this study.
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The investigator will acknowledge the patient’s valuable contribution in participating in
the study and explain the long-term goal of assessing the needs of pancreatic cancer
patients to help clinicians enhance their communication skills and improve the way they
engage patients in health care decisions.
7.0 Data Confidentiality:
The questionnaires will not contain identification information but only a participant
number. Data will only be available to the PI and research team members directly
involved with the collection and analysis of data related to this project. IRB approval will
be obtained for any exchange of data outside of MD Anderson.
The members of the research team will be trained to maintain any patient health
information confidential. Training will be documented as required by institutional policy.
Data Storage: The questionnaires will not contain identification information but only a
participant number. The information key linking the participant number to his or her
identification will be kept separate and secure. The PI and research staff will minimize
risk by only storing information containing subject identifiers in locked file storage, on
password-protected computers, and/or in a password protected database. In addition,
access to patient identifiers will be limited to the minimum number of necessary research
personnel, and only to those research personnel directly involved with obtaining patient
information. Keys containing information linking study subjects to personal identifiers
will be maintained in locked storage for paper records or behind institutionally approved
firewall and electronic security measures for electronic keys, and available ONLY to the
PI and research personnel. Information containing subject personal identifiers will not be
removed from MD Anderson Cancer Center and will not be shared in publications or
reports concerning this research study.
Data Sharing: Study data will not be shared with any individuals or entities that are not
involved in the study. De-identified data may be shared with IRB-approved collaborating
sites (PI’s UT-Health Science Center Dissertation Committee). Sharing of data will be
done only by secured mechanisms, as approved by MD Anderson Information Security.
Final disposition of study records: These data will be used only for this research study.
Data that is in hard-copy form will be retained on site until the study is terminated, and
may be stored indefinitely, per institutional standards, in long-term off-site storage with
an MD Anderson approved, secured contract site. Electronic data will be retained
indefinitely on MD Anderson servers behind the institutional firewall. Data will not be
shared with any party outside of MD Anderson and will not be retained or disseminated
for other research without prior IRB approval.
8.0 Distress Plan
Participants will be provided information on the benefits, and the importance of
knowledge gained from the study. The voluntary nature of the study will be emphasized
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and it will be explained to patients and clinicians that declination of participation in the
study will not affect clinical treatment and/or care.
The Uncertainty in Illness Theory by Mishel defines uncertainty as a cognitive state
wherein there is inability to assign value or meaning to illness-related events. Although
Mishel conceptualized and designed the MUIS-C to measure a cognitive state and
included no questions that address emotional distress, it is recognized that studes in a
cancer population could be have associated distress. Since the MUIS-C manual does not
delineate categories for low/moderate/high levels of uncertainty and because we do not
know the levels of uncertainty in this population as it has not been previously studied, we
cannot use the MUIS-C score to judge low-med-high uncertainty and assign a score that
will prompt implementation of a distress plan. We will observe the patient for signs of
unease or discomfort with the study and also review the responses so that items with
answers that state “strongly agree” or for reservely scored items, those with “strongly
disagree” will be reported to the clinical team so that the patient’s uncertainty over their
disease and management can be addressed.
The clinical team will also be notified if the patient verbalizes distress so that referral for
counseling, supportive care, or psychiatry consult can be intiated. The patient will be
informed that he/she may discontinue participation in the study at any time.
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1.0 Objectives
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel
Uncertainty in Illness Scale – Community instrument (MUIS-C)
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its
association to uncertainty in the pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower
levels of uncertainty in pancreatic cancer patients
Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic
cancer patients after adjusting for age, sex, race, education level, and disease treatment
stage
3. Examine if age, sex, race, education level, and disease treatment stage are significant
predictors of uncertainty and health literacy in the pancreatic cancer population
Hypothesis 3a: Education level, race, disease treatment stage are significant predictors
of uncertainty and of health literacy in pancreatic cancer patients
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of health
literacy in pancreatic cancer patients
The primary aim is to determine if a significant correlation exists between of uncertainty
and health literacy in the pancreatic cancer population (hypothesis 2a). As neither
uncertainty nor health literacy has been studied in this population, exploratory aims are to
describe uncertainty and health literacy in pancreatic cancer patients, and to examine for
significant predictors.
2.0 Rationale
Pancreatic cancer has aggressive biology, vague and distressing symptoms, and lacks
expert agreement on treatment guidelines for patients with potentially-curable, resectable
disease. For patients undergoing treatment, there is debate even among experts regarding
the sequence of therapy for patients with resectable disease (Evans et al., 2008;
Varadhachary et al., 2008). The National Comprehensive Cancer Network (NCCI)
recommends upfront surgery for potentially-resectable pancreatic cancer but expert
consensus and a number of phase II clinical trials support administration of neoadjuvant
chemotherapy in selected patients with biopsy-proven carcinoma prior to surgery
(Halperin & Varadhachary, 2014). Even for patients who complete treatment, the
widely-acknowledged high recurrence rate undermines confidence in having achieved
long-term survival or cure. The 5-year survival rate for pancreatic cancer remains low at
7% (ACS, 2016) and approximately 80% of patients undergoing resection with curative
intent develop distant metastasis or local recurrence within five years of surgery
(Halperin & Varadhachary, 2014). With a grim prognosis, patients can become overly
vigilant and mistakenly interpret symptoms unrelated to malignancy as indications of
disease recurrence. All of these factors contribute to uncertainty, defined as a cognitive
state wherein there is inability to give meaning to illness events (Mishel, 1988, Mishel &
Braden, 1988, Mishel, et al., 2009). ). It is conceptualized by Mishel within the
Uncertainty of Illness Theory as a cognitive state that occurs when the decision maker
unable to assign values to events or is unable to predict outcomes due to cues being
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lacking or insufficient (Bailey, et al., 2011). The framework describes that individuals
cognitively process illness stimuli then through primary appraisal, derive meaning.
Uncertainty has been studied in many cancer populations (Bailey et al., 2011; Cahill et
al., 2014; Elphee, 2008; Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002;
Mishel et al., 2009; Parker et al., 2013) but it has not been studied in pancreatic cancer
patients.
Uncertainty is linked to poor outcomes (Lin et al., 2015) and one factor that can
potentially mitigate uncertainty is health literacy, defined as the capacity to obtain,
process, and understand health information and services needed to make appropriate
health decisions (Dumenci, 2014). Limited health literacy is also associated with
unfavorable outcomes in cancer patients (Mahal, 2015; Busch, 2015: Winton, 2016;
Hawley, 2008; Koay, 2013) and low health literacy is perceived by cancer patients as a
barrier to good outcomes (Rust, 2011; Rust, 2012). Unfortunately, health literacy has not
been studied either with a focus on pancreatic cancer patients whose illness experience
require navigation of complex information and services pathways in order to engage
successfully in treatment decisions.
Despite the shared link to information processing suggested by their definitions, the
relationship between uncertainty and health literacy has not been studied in cancer
patients and has not been studied individually in pancreatic cancer patients. This study
planned within a framework adapted from Mishel Uncertainty Theory will address these
gaps (Mishel, 1988, Mishel & Braden, 1988, Mishel, et al., 2009). The model adapted
from Mishel’s original framework and focused on the antecedent portion of the original
model is illustrated in Figure 1.

Figure 1. Antecendents of Uncertainty in Pancreatic Cancer Patients
Adapted from Mishel’s Uncertainty in Illness Theory (Mishel, 1988).
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In this model, Event Stimuli represents the events during the different phases of diagnosis
and disease management that the patients may experience. The Structure Providers
represent factors that can help the patient interpret illness events. Patient Characteristics
include the patient’s demographics that include age, education level, sex, and race.
The study will examine demographic and factors to evaluate if there are predictors that
can guide future research and identification of individuals who are more susceptible to
uncertainty. Prior health literacy assessment in 1,306 cancer patients found no significant
mean difference between men and women (p=.247) but the scores among African
Americans were found to be significantly lower (p < .0001) than White participants
(Dumenci et al., 2014). This study found that participants with limited health literacy
consisted of an overrepresentation of African-Americans, patients who were
undereducated, and patients with lower income (Dumenci et al., 2014). Meanwhile
aggregate data on different population subgroups described in the Uncertainty in Illness
Scales Manual indicate no difference in the mean scores based on sex or age but that
scores decrease with an increase in level of education (Mishel, 1997). These
demographic variables will be evaluated as this can influence the design and
implementation of future studies and intended population of intervention programs.
Moreover, patient uncertainty has been found to vary according to disease treatment stage
with a brain tumor population study showing variation depending on treatment status
with newly diagnosed patients and patients on active treatment having high levels of
uncertainty (Lin et al., 2015). This will be assessed in pancreatic cancer patients to
facilitate and promote communication between clinicians and patients when making
health care decisions.
3.0 Eligibility of Subjects
INCLUSION CRITERIA
1. Patients with a diagnosis of biopsy-proven pancreatic adenocarcinoma who are
being treated in an Ambulatory Outpatient Clinic at MD Anderson Cancer Center
Main Campus
2. Patients with a diagnosis of pancreatic adenocarcinoma who also
have a history of non-melanoma skin cancer(s) are eligible to
participate
3. Patients who meet the above criteria and are 18 years of age or older
EXCLUSION CRITERIA
1. Patients with pancreatic
adenocarcinoma who have a history
or current diagnosis of another
primary malignancy for which:
 oncologic treatment is currently being administered or has been
administered within past the five years
 there has been evidence of disease within the past five years related to the
patient’s other malignancy
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2. Patients unable to speak, read, or write in English will be excluded because the
study instruments are in English
3. Pancreatic adenocarcinoma patients who are under 18 years of age
4.0 Research Plan and Methods
The study is designed as an observational, cross-sectional study seeking to describe
uncertainty in illness and health literacy in the pancreatic cancer population and explore
the relationship between these variables. Given the absence of prior studies on
uncertainty and health literacy in pancreatic cancer patients, this design is appropriate as
an exploration that can provide groundwork for future research. Written approval prior
to the initiation of the study will be obtained from the Institutional review Board of MD
Anderson. The principal investigator (PI) will provide training to study staff prior to data
collection.
Recruitment:
Patients who meet the eligibility criteria will be invited to participate in the study when
they present for a clinic visit by the investigator and will be approached to obtain
informed consent. This study and the recruitment will be conducted in the outpatient
clinic during a patient’s scheduled visit to the clinic. Patients will not be required to
report to clinic for the purpose of study participation on days when they otherwise do
not have a scheduled visit for cancer treatment or follow-up.
Collaboration and coordination with the clinic team seeing the patients will be
established for the study prior to beginning screening, recruitment, and enrollment. The
eligibility review and recruitment will be as follows:
1.
2.

3.
4.
5.
6.
7.

Primary investigator will pre-screen the patients scheduled to attend
pancreatic cancer clinic in preparation for the research study
Primary investigator will send the list of eligible patients to the clinic team
and obtain permission to recruit the patients in clinic on the day of their
visits
Primary investigator will approach the eligible patients in clinic on a
consecutive basis to explain the study and invite their participation
The primary investigator will explain the Informed Consent process and
voluntary nature of study participation and address patient questions
The principal investigator will obtain signatures for Informed Consent
A copy of the completed consent will be kept in the electronic health
record system
A copy of the completed consent will be offered to the patient and given to
those who want to keep a copy for their personal records

Registration:
Enrolled patients will be registered into the Clinical Oncology Research System (CORe)
which serves as the MD Anderson Cancer Center institutional patient data management
system.
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Data Collection:
The questionnaires will not contain identifiers but will only have a participant number.
Enrolled patients will complete the instruments in the clinic. Collaboration and
coordination with the clinic team seeing the patients will be established for the study prior
to beginning screening, recruitment, and enrollment.
The participants will complete the questionnaires in the clinic room or waiting area before
they are seen by the physician during their visit.
1. Data will be collected by paper and pencil surveys with the investigator entering
information into the web-based REDCap application hosted by MD Anderson
Cancer Center (https://redcap.mdanderson.org)
2. The investigator or a clinical research staff will be available in clinic during the
time the patient is completing the instruments
3. The investigator or research staff may not provide any answers to the specific
questions on the questionnaire but can address questions about study participation
or the process of form completion
4. Only the patient may complete the form. Family members or patient companions
to the visit may not answer or complete the forms. If there are deficits that makes
reading the questionnaire or writing the responses difficult, the questionnaire can
be read to the patient by the research staff or the patient companion and the
responses recorded according to the patient response
5. Investigator or research staff will review the forms to ensure completeness or that
the participant has responded to all the items that want to answer. The primary
investigator will keep the completed forms to a secure location in the primary
investigator’s office
6. Participants will not take home their questionnaires for completion. If a
participant does not complete his or her participation while in clinic, the
participant will not be included in the sample to be analyzed.
Recruitment and informed consents is anticipated to take 20 minutes while the time to
complete the instruments is anticipated to take approximately 20 minutes with a total
participation time of 40 minutes. The primary investigator will enter the data into the
secure RedCap database. Data entry and instrument scoring will be conducted according
to the instrument manuals and study protocol prepared for the study.
INSTRUMENTS
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be used to
measure uncertainty. The MUIS-C has 23 items scored 1 to 5 on a Likert scale. The item
scores are summed with a higher cumulative score indicating greater uncertainty. The
MUIS-C has been used extensively with cancer patients. The MUIS-C was adapted from
the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally developed to
evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 2011). Items from
the MUIS-A specifically relating to inpatient hospitalization were removed and the
remaining questions comprise the items for the MUIS-C version. The MUIS-A was
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developed through expert analysis and validation of the MUIS-A was utilized to support
the validity of the MUIS-C (Bailey et al., 2011). In analyses of MUIS-C scores from 18
samples of chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a
large majority of the samples indicating the reliability of MUIS-C as comparable to the
0.87 reported for the MUIS-A (Bailey et al., 2011). Scores can range from 23 to 115
with a higher score indicating higher uncertainty. There is no categorical delineation
regarding what is considered as “low”, “moderate” or “high” uncertainty.
The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be used to
measure health literacy. The 30-item CHLT-30 was created to assess literacy along the
cancer health literacy continuum. Its development was described in a publication of a
study involving 1,306 adults with heterogenous cancer diagnoses, educational attainment,
and health insurance and marital status. Pancreatic cancer was not listed as a category
among the 11 diagnostic cancer types represented by the participants in the study sample.
The reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of
0.90. There was support for the unidimensional scale and all variables had significant
factor loadings of > 0.44. Structural equation modeling supported external validity with
self-confidence in engaging in health decisions specified as a latent variable measured by
two positively and two negatively worded items. The test score is the total number of
correct responses and ranges from 0 to 30. The instrument response time ranges from 1015 minutes (Dumenci, et. al., 2014).
A Patient Demographic Form will be utilized to record demographic information
including age, sex, education level, race, and disease treatment stage.
5.0 Statistics and Justification of Sample Size
The sample size calculation is based on the primary aim to determine a correlation
between uncertainty and health literacy. An estimated total of up to 91 patients will be
invited to participate. With an anticipated response rate of approximately 90%, an
analyzable sample size of 82 will be produced. The primary objective is to collect the
uncertainty and health literacy information in pancreatic cancer patients and assess the
correlation between uncertainty and health literacy. The primary endpoints are the
Mishel uncertainty scores, which is defined as the summation of all the questions
scores and the cancer health literacy test scores which is defined as the number of
questions that the patient answers correctly. With 82 patients in total, given the twosided type I error of 5%, we will have an 80% power to detect a Pearson’s correlation
of 0.3 between uncertainty score and cancer health literacy score. nQuery/nTerim
version 3.0 was used for the sample size justification.
Questionnaire scores will be calculated based on standardized manuals associated with
each survey instrument. Descriptive statistics will be used to summarize scores of the
questionnaires according to respective scoring manuals for each of the measures. The
distribution of each continuous variable will be summarized by its mean, standard
deviation, median, and range. The distribution of each categorical variable will be
summarized in terms of its frequencies and percentages. The difference in uncertainty
and health literacy scores will be assessed between groups (e.g. gender, education
levels) by a two-sample t-test or ANOVA if the data is normally distributed; otherwise
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a Wilcoxon rank sum or Kruskal-Wallis test will be used. The association between
uncertainty scores and health literacy score will be examined by Pearson correlation.
To identify factors associated with uncertainty or health literacy scores of the survey
measures, for example, the patient education level, age, race, and gender, multivariate
linear regression will be performed to examine their effects. Specifically, the
hypotheses testing and anticipated results are as follows:
1.

Describe uncertainty in the pancreatic cancer patient population using the MUIS this primary, exploratory aim will assessed using Descriptive Analysis and Analysis
of Variance (ANOVA)

2.

Describe health literacy using the CHLT-30 and its association to uncertainty in the
pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with
lower levels of uncertainty in pancreatic cancer patients - Pearson product
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho
will be used if there is not a linear relationship or normal distribution. The
anticipated result will be an inverse linear association between uncertainty and
health literacy.
Hypothesis 2b: Health literacy is an independent significant predictor of
uncertainty in pancreatic cancer patients after adjusting for age, sex, education
level, race, disease treatment stage - Health literacy will be included in
multivariate regression to evaluate if it is a significant predictor of uncertainty after
adjusting for other variables under study.

3.

Examine significant demographic predictors of uncertainty and health literacy in the
pancreatic cancer population
Hypothesis 3a: Education level, race, disease treatment stage are significant
predictors of uncertainty and of health literacy in pancreatic cancer patients –
Multiple linear regression will be performed to determine if these variables are
significant predictors for uncertainty and multivariate regression will be also be
performed to assess if they are significant predictors for health literacy as well. The
anticipated results will be that education level, race, and disease treatment stage will
be significant predictors for both health literacy and uncertainty.
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of
health literacy in pancreatic cancer patients - Multivariate regression will be
performed to determine if age and sex are significant predictors for uncertainty and
multivariate regression will be also be performed assess if they are significant
predictors for health literacy as well. The anticipated results will be that neither age
not sex will come out as significant predictors for either uncertainty or health
literacy.

6.0 Informed Consent Process
Participants 18 years of age and older will be consented in the clinic during scheduled
visits. They will be consented by the study PI or by authorized, trained research personnel
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listed on the Delegation of Authority. This study has minimal risks and does not provide
treatment.
Patients will be given the opportunity to review study documents and ask questions, and
will be given time to consider their participation prior to signing the consent. This study
is limited to English-speaking patients, due to the instruments only being available in
English, therefore, patients who are unable to read, write, and understand English will not
be consented to this study.
The investigator will acknowledge the patient’s valuable contribution in participating in
the study and explain the long-term goal of assessing the needs of pancreatic cancer
patients to help clinicians enhance their communication skills and improve the way they
engage patients in health care decisions.
7.0 Data Confidentiality:
The questionnaires will not contain identification information but only a participant
number. Data will only be available to the PI and research team members directly
involved with the collection and analysis of data related to this project. IRB approval will
be obtained for any exchange of data outside of MD Anderson.
The members of the research team will be trained to maintain any patient health
information confidential. Training will be documented as required by institutional policy.
Data Storage: The questionnaires will not contain identification information but only a
participant number. The information key linking the participant number to his or her
identification will be kept separate and secure. The PI and research staff will minimize
risk by only storing information containing subject identifiers in locked file storage, on
password-protected computers, and/or in a password protected database. In addition,
access to patient identifiers will be limited to the minimum number of necessary research
personnel, and only to those research personnel directly involved with obtaining patient
information. Keys containing information linking study subjects to personal identifiers
will be maintained in locked storage for paper records or behind institutionally approved
firewall and electronic security measures for electronic keys, and available ONLY to the
PI and research personnel. Information containing subject personal identifiers will not be
removed from MD Anderson Cancer Center and will not be shared in publications or
reports concerning this research study.
Data Sharing: Study data will not be shared with any individuals or entities that are not
involved in the study. De-identified data may be shared with IRB-approved collaborating
sites (PI’s UT-Health Science Center Dissertation Committee). Sharing of data will be
done only by secured mechanisms, as approved by MD Anderson Information Security.
Final disposition of study records: These data will be used only for this research study.
Data that is in hard-copy form will be retained on site until the study is terminated, and
may be stored indefinitely, per institutional standards, in long-term off-site storage with
an MD Anderson approved, secured contract site. Electronic data will be retained
indefinitely on MD Anderson servers behind the institutional firewall. Data will not be
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shared with any party outside of MD Anderson and will not be retained or disseminated
for other research without prior IRB approval.
8.0 Distress Plan
Participants will be provided information on the benefits, and the importance of
knowledge gained from the study. The voluntary nature of the study will be emphasized
and it will be explained to patients and clinicians that declination of participation in the
study will not affect clinical treatment and/or care.
The Uncertainty in Illness Theory by Mishel defines uncertainty as a cognitive state
wherein there is inability to assign value or meaning to illness-related events. Although
Mishel conceptualized and designed the MUIS-C to measure a cognitive state and
included no questions that address emotional distress, it is recognized that studes in a
cancer population could be have associated distress. Since the MUIS-C manual does not
delineate categories for low/moderate/high levels of uncertainty and because we do not
know the levels of uncertainty in this population as it has not been previously studied, we
cannot use the MUIS-C score to judge low-med-high uncertainty and assign a score that
will prompt implementation of a distress plan. We will observe the patient for signs of
unease or discomfort with the study and also review the responses so that items with
answers that state “strongly agree” or for reservely scored items, those with “strongly
disagree” will be reported to the clinical team so that the patient’s uncertainty over their
disease and management can be addressed.
The clinical team will also be notified if the patient verbalizes distress so that referral for
counseling, supportive care, or psychiatry consult can be intiated. The patient will be
informed that he/she may discontinue participation in the study at any time.
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1.0 Objectives
1. Describe uncertainty in the pancreatic cancer patient population using the Mishel
Uncertainty in Illness Scale – Community instrument (MUIS-C)
2. Describe health literacy using the Cancer Health Literacy Test – 30 (CHLT-30) and its
association to uncertainty in the pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with lower
levels of uncertainty in pancreatic cancer patients
Hypothesis 2b: Health literacy is an independent predictor of uncertainty in pancreatic
cancer patients after adjusting for age, sex, race, education level, and disease treatment
stage
3. Examine if age, sex, race, education level, and disease treatment stage are significant
predictors of uncertainty and health literacy in the pancreatic cancer population
Hypothesis 3a: Education level, race, disease treatment stage are significant predictors
of uncertainty and of health literacy in pancreatic cancer patients
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of health
literacy in pancreatic cancer patients
The primary aim is to determine if a significant correlation exists between of uncertainty
and health literacy in the pancreatic cancer population (hypothesis 2a). As neither
uncertainty nor health literacy has been studied in this population, exploratory aims are to
describe uncertainty and health literacy in pancreatic cancer patients, and to examine for
significant predictors.
2.0 Rationale
Pancreatic cancer has aggressive biology, vague and distressing symptoms, and lacks
expert agreement on treatment guidelines for patients with potentially-curable, resectable
disease. For patients undergoing treatment, there is debate even among experts regarding
the sequence of therapy for patients with resectable disease (Evans et al., 2008;
Varadhachary et al., 2008). The National Comprehensive Cancer Network (NCCI)
recommends upfront surgery for potentially-resectable pancreatic cancer but expert
consensus and a number of phase II clinical trials support administration of neoadjuvant
chemotherapy in selected patients with biopsy-proven carcinoma prior to surgery
(Halperin & Varadhachary, 2014). Even for patients who complete treatment, the
widely-acknowledged high recurrence rate undermines confidence in having achieved
long-term survival or cure. The 5-year survival rate for pancreatic cancer remains low at
7% (ACS, 2016) and approximately 80% of patients undergoing resection with curative
intent develop distant metastasis or local recurrence within five years of surgery
(Halperin & Varadhachary, 2014). With a grim prognosis, patients can become overly
vigilant and mistakenly interpret symptoms unrelated to malignancy as indications of
disease recurrence. All of these factors contribute to uncertainty, defined as a cognitive
state wherein there is inability to give meaning to illness events (Mishel, 1988, Mishel &
Braden, 1988, Mishel, et al., 2009). ). It is conceptualized by Mishel within the
Uncertainty of Illness Theory as a cognitive state that occurs when the decision maker
unable to assign values to events or is unable to predict outcomes due to cues being
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lacking or insufficient (Bailey, et al., 2011). The framework describes that individuals
cognitively process illness stimuli then through primary appraisal, derive meaning.
Uncertainty has been studied in many cancer populations (Bailey et al., 2011; Cahill et
al., 2014; Elphee, 2008; Germino et al., 2013; McCorkle et al., 2009; Mishel et al., 2002;
Mishel et al., 2009; Parker et al., 2013) but it has not been studied in pancreatic cancer
patients.
Uncertainty is linked to poor outcomes (Lin et al., 2015) and one factor that can
potentially mitigate uncertainty is health literacy, defined as the capacity to obtain,
process, and understand health information and services needed to make appropriate
health decisions (Dumenci, 2014). Limited health literacy is also associated with
unfavorable outcomes in cancer patients (Mahal, 2015; Busch, 2015: Winton, 2016;
Hawley, 2008; Koay, 2013) and low health literacy is perceived by cancer patients as a
barrier to good outcomes (Rust, 2011; Rust, 2012). Unfortunately, health literacy has not
been studied either with a focus on pancreatic cancer patients whose illness experience
require navigation of complex information and services pathways in order to engage
successfully in treatment decisions.
Despite the shared link to information processing suggested by their definitions, the
relationship between uncertainty and health literacy has not been studied in cancer
patients and has not been studied individually in pancreatic cancer patients. This study
planned within a framework adapted from Mishel Uncertainty Theory will address these
gaps (Mishel, 1988, Mishel & Braden, 1988, Mishel, et al., 2009). The model adapted
from MIshel’s orginal framework and focused on the antecedent portion of the original
model is illustrated in Figure 1.

Figure 1. Antecendents of Uncertainty in Pancreatic Cancer Patients
Adapted from Mishel’s Uncertainty in Illness Theory (Mishel, 1988).
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In this model, Event Stimuli represents the events during the different phases of diagnosis
and disease management that the patients may experience. The Structure Providers
represent factors that can help the patient interpret illness events. Patient Characteristics
include the patient’s demographics that include age, education level, sex, and race.
The study will examine demographic and factors to evaluate if there are predictors that
can guide future research and identification of individuals who are more susceptible to
uncertainty. Prior health literacy assessment in 1,306 cancer patients found no significant
mean difference between men and women (p=.247) but the scores among African
Americans were found to be significantly lower (p < .0001) than White participants
(Dumenci et al., 2014). This study found that participants with limited health literacy
consisted of an overrepresentation of African-Americans, patients who were
undereducated, and patients with lower income (Dumenci et al., 2014). Meanwhile
aggregate data on different population subgroups described in the Uncertainty in Illness
Scales Manual indicate no difference in the mean scores based on sex or age but that
scores decrease with an increase in level of education (Mishel, 1997). These
demographic variables will be evaluated as this can influence the design and
implementation of future studies and intended population of intervention programs.
Moreover, patient uncertainty has been found to vary according to disease treatment stage
with a brain tumor population study showing variation depending on treatment status
with newly diagnosed patients and patients on active treatment having high levels of
uncertainty (Lin et al., 2015). This will be assessed in pancreatic cancer patients to
facilitate and promote communication between clinicians and patients when making
health care decisions.
3.0 Eligibility of Subjects
Inclusion Criteria
1. Patients with a diagnosis of pancreatic adenocarcinoma who are being treated in
an Ambulatory Outpatient Clinic at MD Anderson Cancer Center Main Campus
2. Patients with a diagnosis of pancreatic adenocarcinoma who are 18 years old or
older
Exclusion Criteria
1. Patients with pancreatic adenocarcinoma who have:
a. evidence of active disease, metastasis, or recurrence of another primary
malignancy, except non-melanoma skin cancer, within the past 5 years
b. a personal history of another primary malignancy, except non-melanoma
skin cancer, for which oncologic treatment has been administered within
the past 5 years
2. Patients unable to speak, read, or write in English
3. Pancreatic adenocarcinoma patients who are under 18 years of age
4.0 Research Plan and Methods
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The study is designed as an observational, cross-sectional study seeking to describe
uncertainty in illness and health literacy in the pancreatic cancer population and explore
the relationship between these variables. Given the absence of prior studies on
uncertainty and health literacy in pancreatic cancer patients, this design is appropriate as
an exploration that can provide groundwork for future research. Written approval prior
to the initiation of the study will be obtained from the Institutional review Board of MD
Anderson. The principal investigator (PI) will provide training to study staff prior to data
collection.
Recruitment:
Patients who meet the eligibility criteria will be invited to participate in the study when
they present for a clinic visit by the investigator and will be approached to obtain
informed consent. This study and the recruitment will be conducted in the outpatient
clinic during a patient’s scheduled visit to the clinic. Patients will not be required to
report to clinic for the purpose of study participation on days when they otherwise do
not have a scheduled visit for cancer treatment or follow-up.
Collaboration and coordination with the clinic team seeing the patients will be
established for the study prior to beginning screening, recruitment, and enrollment. The
eligibility review and recruitment will be as follows:
1.

Primary investigator will pre-screen the patients scheduled to attend
pancreatic cancer clinic in preparation for the research study
2.
Primary investigator will send the list of eligible patients to the clinic team
and obtain permission to recruit the patients in clinic on the day of their
visits
3.
Primary investigator will approach the eligible patients in clinic on a
consecutive basis to explain the study and invite their participation
4. The primary investigator will explain the Informed Consent process and voluntary
nature of study participation and address patient questions
5.
The principal investigator will obtain signatures for Informed Consent
6.
A copy of the completed consent will be kept in the electronic health
record system
7.
A copy of the completed consent will be offered to the patient and given to
those who want to keep a copy for their personal records

Registration:
Enrolled patients will be registered into the Clinical Oncology Research System (CORe)
which serves as the MD Anderson Cancer Center institutional patient data management
system.
Data Collection:
The questionnaires will not contain identifiers but will only have a participant number.
Enrolled patients will complete the instruments in the clinic. Collaboration and
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coordination with the clinic team seeing the patients will be established for the study prior
to beginning screening, recruitment, and enrollment.
The participants will complete the MUIS-C questionnaires measuring uncertainty in the
clinic room or waiting area before they are seen by the physician during their visit.
1. Data will be collected by paper and pencil surveys with the investigator entering
information into the web-based REDCap application hosted by MD Anderson
Cancer Center (https://redcap.mdanderson.org)
2. The investigator or a clinical research staff will be available in clinic during the
time the patient is completing the instruments
3. The investigator or research staff may not provide any answers to the specific
questions on the questionnaire but can address questions about study participation
or the process of form completion
4. Only the patient may complete the form. Family members or patient companions
to the visit may not answer or complete the forms. If there are deficits that makes
reading the questionnaire or writing the responses difficult, the questionnaire can
be read to the patient by the research staff or the patient companion and the
responses recorded according to the patient response
5. Investigator or research staff will review the forms to ensure completeness or that
the participant has responded to all the items that want to answer. The primary
investigator will keep the completed forms to a secure location in the primary
investigator’s office
6. Participants will not take home their questionnaires for completion. If a
participant does not complete his or her participation while in clinic, the
participant will not be included in the sample to be analyzed.
Recruitment and informed consents is anticipated to take 20 minutes while the time to
complete the instruments is anticipated to take approximately 20 minutes with a total
participation time of 40 minutes. The primary investigator will enter the data into the
secure RedCap database. Data entry and instrument scoring will be conducted according
to the instrument manuals and study protocol prepared for the study.
INSTRUMENTS
The Mishel Uncertainty in Illness Scale – Community Form (MUIS-C) will be used to
measure uncertainty. The MUIS-C has 23 items scored 1 to 5 on a Likert scale. The item
scores are summed with a higher cumulative score indicating greater uncertainty. The
MUIS-C has been used extensively with cancer patients. The MUIS-C was adapted from
the 33-item Mishel Uncertainty in Illness Scale (MUIS-A), originally developed to
evaluate uncertainty in acutely ill, hospitalized adults (Bailey et al., 2011). Items from
the MUIS-A specifically relating to inpatient hospitalization were removed and the
remaining questions comprise the items for the MUIS-C version. The MUIS-A was
developed through expert analysis and validation of the MUIS-A was utilized to support
the validity of the MUIS-C (Bailey et al., 2011). In analyses of MUIS-C scores from 18
samples of chronically ill adults (total n=1068), Cronbach’s alpha exceeded 0.85 in a
large majority of the samples indicating the reliability of MUIS-C as comparable to the
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0.87 reported for the MUIS-A (Bailey et al., 2011). Scores can range from 23 to 115
with a higher score indicating higher uncertainty. There is no categorical delineation
regarding what is considered as “low”, “moderate” or “high” uncertainty.
The Cancer Health Literacy Test – 30 (CHLT-30) (Dumenci, et. al., 2014) will be used to
measure health literacy. The 30-item CHLT-30 was created to assess literacy along the
cancer health literacy continuum. Its development was described in a publication of a
study involving 1,306 adults with heterogenous cancer diagnoses, educational attainment,
and health insurance and marital status. Pancreatic cancer was not listed as a category
among the 11 diagnostic cancer types represented by the participants in the study sample.
The reliability evidence for the CHLT-30 was a Cronbach’s alpha of 0.88, McDonald’s
omega of 0.89, 2-week test–retest reliability of 0.90, and 6-month test–retest reliability of
0.90. There was support for the unidimensional scale and all variables had significant
factor loadings of > 0.44. Structural equation modeling supported external validity with
self-confidence in engaging in health decisions specified as a latent variable measured by
two positively and two negatively worded items. The test score is the total number of
correct responses and ranges from 0 to 30. The instrument response time ranges from 1015 minutes (Dumenci, et. al., 2014). A Patient Demographic Form will be utilized to
record demographic information including age, sex, education level, race, and disease
treatment stage.
5.0 Statistics and Justification of Sample Size
The sample size calculation is based on the primary aim to determine a correlation
between uncertainty and health literacy. An estimated total of up to 91 patients will be
invited to participate. With an anticipated response rate of approximately 90%, an
analyzable sample size of 82 will be produced. The primary objective is to collect the
uncertainty and health literacy information in pancreatic cancer patients and assess the
correlation between uncertainty and health literacy. The primary endpoints are the
Mishel uncertainty scores, which is defined as the summation of all the questions
scores and the cancer health literacy test scores which is defined as the number of
questions that the patient answers correctly. With 82 patients in total, given the twosided type I error of 5%, we will have an 80% power to detect a Pearson’s correlation
of 0.3 between uncertainty score and cancer health literacy score. nQuery/nTerim
version 3.0 was used for the sample size justification.
Questionnaire scores will be calculated based on standardized manuals associated with
each survey instrument. Descriptive statistics will be used to summarize scores of the
questionnaires according to respective scoring manuals for each of the measures. The
distribution of each continuous variable will be summarized by its mean, standard
deviation, median, and range. The distribution of each categorical variable will be
summarized in terms of its frequencies and percentages. The difference in uncertainty
and health literacy scores will be assessed between groups (e.g. gender, education
levels) by a two-sample t-test or ANOVA if the data is normally distributed; otherwise
a Wilcoxon rank sum or Kruskal-Wallis test will be used. The association between
uncertainty scores and health literacy score will be examined by Pearson correlation.
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To identify factors associated with uncertainty or health literacy scores of the survey
measures, for example, the patient education level, age, race, and gender, multivariate
linear regression will be performed to examine their effects.

Specifically, the hypotheses testing and anticipated results are as follows:
1. Describe uncertainty in the pancreatic cancer patient population using the MUIS this primary, exploratory aim will assessed using Descriptive Analysis and Analysis
of Variance (ANOVA)
2.

Describe health literacy using the CHLT-30 and its association to uncertainty in the
pancreatic cancer patient population
Hypothesis 2a: Higher levels of health literacy are significantly correlated with
lower levels of uncertainty in pancreatic cancer patients - Pearson product
moment correlation coefficient will be calculated. Kendall’s tau b or Spearman rho
will be used if there is not a linear relationship or normal distribution. The
anticipated result will be an inverse linear association between uncertainty and
health literacy.
Hypothesis 2b: Health literacy is an independent significant predictor of
uncertainty in pancreatic cancer patients after adjusting for age, sex, education
level, race, disease treatment stage - Health literacy will be included in
multivariate regression to evaluate if it is a significant predictor of uncertainty after
adjusting for other variables under study.

3.

Examine significant demographic predictors of uncertainty and health literacy in the
pancreatic cancer population
Hypothesis 3a: Education level, race, disease treatment stage are significant
predictors of uncertainty and of health literacy in pancreatic cancer patients –
Multiple linear regression will be performed to determine if these variables are
significant predictors for uncertainty and multivariate regression will be also be
performed to assess if they are significant predictors for health literacy as well. The
anticipated results will be that education level, race, and disease treatment stage will
be significant predictors for both health literacy and uncertainty.
Hypothesis 3b: Age and sex are not significant predictors of uncertainty or of
health literacy in pancreatic cancer patients - Multivariate regression will be
performed to determine if age and sex are significant predictors for uncertainty and
multivariate regression will be also be performed assess if they are significant
predictors for health literacy as well. The anticipated results will be that neither age
not sex will come out as significant predictors for either uncertainty or health
literacy.

6.0 Informed Consent Process
Participants 18 years of age and older will be consented in the clinic during scheduled
visits. They will be consented by the study PI or by authorized, trained research personnel
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listed on the Delegation of Authority. This study has minimal risks and does not provide
treatment.
Patients will be given the opportunity to review study documents and ask questions, and
will be given time to consider their participation prior to signing the consent. This study
is limited to English-speaking patients, due to the instruments only being available in
English, therefore, patients who are unable to read, write, and understand English will not
be consented to this study.
The investigator will acknowledge the patient’s valuable contribution in participating in
the study and explain the long-term goal of assessing the needs of pancreatic cancer
patients to help clinicians enhance their communication skills and improve the way they
engage patients in health care decisions.
7.0 Data Confidentiality:
The questionnaires will not contain identification information but only a participant
number. Data will only be available to the PI and research team members directly
involved with the collection and analysis of data related to this project. IRB approval will
be obtained for any exchange of data outside of MD Anderson.
The members of the research team will be trained to maintain any patient health
information confidential. Training will be documented as required by institutional policy.
Data Storage: The questionnaires will not contain identification information but only a
participant number. The information key linking the participant number to his or her
identification will be kept separate and secure. The PI and research staff will minimize
risk by only storing information containing subject identifiers in locked file storage, on
password-protected computers, and/or in a password protected database. In addition,
access to patient identifiers will be limited to the minimum number of necessary research
personnel, and only to those research personnel directly involved with obtaining patient
information. Keys containing information linking study subjects to personal identifiers
will be maintained in locked storage for paper records or behind institutionally approved
firewall and electronic security measures for electronic keys, and available ONLY to the
PI and research personnel. Information containing subject personal identifiers will not be
removed from MD Anderson Cancer Center and will not be shared in publications or
reports concerning this research study.
Data Sharing: Study data will not be shared with any individuals or entities that are not
involved in the study. De-identified data may be shared with IRB-approved collaborating
sites (PI’s UT-Health Science Center Dissertation Committee). Sharing of data will be
done only by secured mechanisms, as approved by MD Anderson Information Security.
Final disposition of study records: These data will be used only for this research study.
Data that is in hard-copy form will be retained on site until the study is terminated, and
may be stored indefinitely, per institutional standards, in long-term off-site storage with
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an MD Anderson approved, secured contract site. Electronic data will be retained
indefinitely on MD Anderson servers behind the institutional firewall. Data will not be
shared with any party outside of MD Anderson and will not be retained or disseminated
for other research without prior IRB approval.
8.0 Distress Plan
Participants will be provided information on the benefits, and the importance of
knowledge gained from the study. The voluntary nature of the study will be emphasized
and it will be explained to patients and clinicians that declination of participation in the
study will not affect clinical treatment and/or care.
The Uncertainty in Illness Theory by Mishel defines uncertainty as a cognitive state
wherein there is inability to assign value or meaning to illness-related events. Although
Mishel conceptualized and designed the MUIS-C to measure a cognitive state and
included no questions that address emotional distress, it is recognized that studes in a
cancer population could be have associated distress. Since the MUIS-C manual does not
delineate categories for low/moderate/high levels of uncertainty and because we do not
know the levels of uncertainty in this population as it has not been previously studied, we
cannot use the MUIS-C score to judge low-med-high uncertainty and assign a score that
will prompt implementation of a distress plan. We will observe the patient for signs of
unease or discomfort with the study and also review the responses so that items with
answers that state “strongly agree” or for reservely scored items, those with “strongly
disagree” will be reported to the clinical team so that the patient’s uncertainty over their
disease and management can be addressed.
The clinical team will also be notified if the patient verbalizes distress so that referral for
counseling, supportive care, or psychiatry consult can be intiated. The patient will be
informed that he/she may discontinue participation in the study at any time.
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